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ABSTRACT 
In this thesis we have investigated the mechanisms of white adipocyte regulated 
exocytosis in health and disease, with a special focus on adiponectin. We have 
applied a combination of electrophysiological membrane capacitance measurements, 
biochemical measurements of released adipokines and gene expression analysis. Our 
work hypothesis was that since white adipocytes are endocrine cells, secretion of 
adipocyte hormones should be regulated in a way resembling how hormone secretion 
is controlled in other endocrine cell types. In paper I we show that adipocyte 
exocytosis is triggered by cAMP via activation of exchange proteins directly 
activated by cAMP (Epac). cAMP triggers secretion of a readily releasable pool of 
vesicles in a Ca2+-independent manner. However, a combination of Ca2+ and ATP 
augments exocytosis via a direct effect on the release process and by recruitment of 
new releasable vesicles. We further demonstrate that recorded membrane capacitance 
increases can be largely correlated to release of adiponectin containing vesicles and 
that the regulation of adiponectin exocytosis is similarly controlled in primary human 
subcutaneous adipocytes. In paper II we show that the Ca2+/ATP-dependent 
maturation of adiponectin vesicles is a temperature-dependent step and thus reduced 
by cooling. We suggest that the temperature-dependent effects reflect the need of 
ATP hydrolysis in order to provide energy for recruitment of new releasable vesicles 
as well as for phosphorylation of exocytotic proteins. Our study provides important 
mechanistic information about the regulation of white adipocyte stimulus-secretion 
coupling. In paper III we show that adiponectin exocytosis is physiologically 
stimulated via adrenergic signalling chiefly involving catecholamine activation of  
β3-adrenergic receptors. We also demonstrate that Epac1 is the isoform expressed in 
white adipocytes. We moreover show that adrenergic stimulation of adiponectin 
exocytosis is disturbed in adipocytes isolated from obese/type-2 diabetic mice and 
that the disruption is due to a low abundance of β3-adrenergic receptors in 
combination with a reduced expression of Epac1. 
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[Ca2+]i    Intracellular Ca2+ concentration 
AC  Adenylate cyclase 
AdipoR1  Adiponectin receptor 1 
AdipoR2  Adiponectin receptor 2 
AR  Adrenergic receptor 
ATP  Adenosine triphosphate 
BAPTA  1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-
tetraacetic acid) 
BAT  Brown adipose tissue 
cAMP  Cyclic adenosine monophosphate 
CL  CL 316,243 
Cm  Membrane capacitance 
CREB  cAMP response element-binding protein 
C/EBPs  CCAAT-enhancer-binding protein 
DEXA  Dexamethasone 
EC  Extracellular solution 
EGTA  Ethylene glycol tetraacetic acid 
ELISA  Enzyme-linked immunosorbent assay 
Epac  Exchange proteins directly activated by cAMP 
ER  Endoplasmic reticulum 
Forsk  Forskolin 
GABA  Gamma-aminobutyric acid 
GDP  Guanosine diphosphate 
GEF  Guanine nucleotide exchange factor 
GPCR  G protein-coupled receptor 
G protein  Guanine nucleotide-binding protein  
GTP  Guanosine triphosphate  
HFD  High fat diet 
HMW  High molecular weight 
IBMX  3-isobutyl-1-metylxanthine 
IL-6  Interleukin 6 
IWAT  Inguinal white adipose tissue 
LMW  Low molecular weight 
NCS  Newborn calf serum 
PDE  Phosphodiesterase 
PI3K  Phosphoinositide 3-kinase 
PKA  Protein kinase A 
PKB  Protein kinase B 
PPARγ  Peroxisome proliferator activated receptor gamma 
RT-PCR  Reverse transcriptase polymerase chain reaction 
SNARE  Soluble N-ethylmaleimide-sensitive factor  
attachment protein receptor proteins 
TIRF  Total internal reflection fluorescence  
TNF-α  Tumor necrosis factor alpha 
WAT  White adipose tissue 
ΔC/Δt  Rate of exocytosis (F/s) 
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Introduction 
In 2014 the World Health Organization announced that more than 1.9 billion adults 
were overweight and that 600 million of these were obese. The obese state can lead 
to many different pathological conditions such as cardiovascular diseases, type 2 
diabetes and certain cancers (Lavie et al., 2009). In fact, overweight and obesity is 
more closely linked to death than underweight. Obesity is characterized by an 
increase in white adipose tissue mass, the body’s fat storing organ. Historically, 
adipose tissue has been viewed as an inert storage depot of fat to be used when 
energy requirements are not met by energy input (Kershaw & Flier, 2004). However, 
growing evidence during the last two decades shows that white adipose tissue 
secretes a wide variety of hormones and bioactive molecules with important roles in 
control of whole-body physiology (Trujillo & Scherer, 2006). One of the protein 
hormones secreted by the white adipocyte, adiponectin, has many improving effects 
in metabolic disease (Whitehead et al., 2006). In obesity, there is a dysregulation of 
adiponectin secretion resulting in decreased levels of this protective hormone. 
20 years after its discovery the mechanisms regulating adiponectin release remain 
unclear. In this thesis, we aim to investigate the intracellular mediators involved in 
the acute release of adiponectin and how this release might be disturbed in obesity 
and type 2 diabetes. 
Adipose tissue 
The main types of adipose tissues are white adipose tissue (WAT) and brown adipose 
tissue (BAT). Another long known but less studied distinct type of adipose tissue is 
bone marrow adipose tissue (Fazeli et al., 2013). 
Adipose tissue is situated in different depots throughout the body with functional as 
well as morphological differences depending on both the adipose tissue type and 
location (Cousin et al., 1993; Frayn et al., 2003; Cinti, 2012). In humans, WAT is 
situated subcutaneously (under the skin) or viscerally (around the internal organs; 
Fig. 1). In rodents, there are several subcutaneous and visceral depots (depicted in 
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Fig. 3 of Cinti, 2005). WAT to BAT ratio is determined 
based on several factors such as age, nutrition and 
environmental conditions (Cinti, 2005; Berry et al., 2013). 
WAT has several important roles in metabolism including 
energy storage and secretion of many bioactive molecules 
with central and peripheral effects. BAT has a protective 
role in cold environments by non-shivering heat production. 
The brown color of BAT is due to a high content of 
mitochondria which specifically express uncoupling protein 
1 (UCP-1). Cold stimulates the release of norepinephrine 
from sympathetic nerves which in turn stimulates lipolysis. 
Subsequently, UCP-1 uncouples oxidative metabolism from 
ATP production with succeeding generation of heat 
(Cannon & Nedergaard, 2004). 
White adipose tissue cell types 
The white adipocyte (Fig. 2), the classical fat cell, is the main cell type of adipose 
tissue. The white adipocyte is a large and expandable cell and human adipocytes can 
vary from 25-250 µM in size (Meyer et al., 2013). The adipocyte is unique in its lipid 
storing properties and contains one large lipid droplet which comprises about 95% of 
the cell volume. The remaining 5% consist of the cell cytosol and nucleus, which are 
localized in close proximity to the plasma membrane. The adipose tissue can grow in 
size by hypertrophy or hyperplasia (Hausman et al., 2001). Hypertrophy in this 
context is the enlargement of adipocytes due to increased lipid accumulation. 














    
   
  
   
  









Fig. 1  
1) Subcutaneous fat  
2) Abdominal muscle 
3) Visceral fat 
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Besides adipocytes, adipose tissue contains other cell types collectively termed the 
stromal vascular fraction. The stromal vascular fraction includes preadipocytes, 
macrophages, monocytes, endothelial cells, pericytes as well as multipotent stem 
cells (Zuk et al., 2002). Preadipocytes can be differentiated into mature adipocytes 
but the mechanisms involved in the recruitment and proliferation of preadipocytes 
are unclear (Hausman et al., 2001; Arner & Spalding, 2010). Interestingly, it has 
been shown that despite a continuous turnover of adipocytes the number of 
adipocytes in humans can vary during childhood and adolescence but remains 
constant and tightly regulated in adulthood (Spalding et al., 2008). Macrophages are 
involved in clearing dead adipocytes within the tissue and their proliferation 
increases specifically in adipose tissue with obesity (Cinti et al., 2005; Amano et al., 
2014). Macrophages release inflammatory factors such as tumor necrosis factor-
alpha (TNF- α) and chronic inflammation in obesity is closely related to insulin 
resistance (H. Xu et al., 2003). 
White adipose tissue vascularisation and innervation 
Adipose tissue is highly vascularised and sufficient blood supply is essential for its 
proper function (Rupnick et al., 2002; Nishimura et al., 2007). Besides providing 
oxygen, lipids and nutrients to the WAT, blood enables the transportation of released 
free fatty acids and adipokines from the WAT to peripheral tissues. Likewise, 
adipose tissue can be exposed to various signaling molecules secreted into the blood 
stream. Microvascularisation of the adipose tissue itself enables paracrine signaling 
with neighbouring cells. The growth of WAT is highly dependent on angiogenesis 
which can be provided by endothelial cells and pericytes in the WAT (Rupnick et al., 
2002). Vascular endothelial growth factor A is proangiogenic and is secreted by 
neighbouring adipocytes and macrophages (Sung et al., 2013). 
The sympathetic innervation of WAT vasculature has been known for many years 
(Slavin & Ballard, 1978) and in 1995 WAT was shown to be directly innervated with 
postganglionic neurons from the sympathetic nervous system (Youngstrom & 
Bartness, 1995; Bamshad et al., 1998). In this way WAT can be directly exposed to 
noradrenaline to activate its adrenergic receptors. Most studies conducted have not 
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shown any significant parasympathetic innervation of WAT, however, the existence 
of parasympathetic innervation is debated and remains to be clarified (Berthoud et 
al., 2006; Giordano et al., 2006; Kreier & Buijs, 2007). 
Adipose tissue in lipid and glucose homeostasis 
One of the important and long-known roles of white adipose tissue is its function in 
maintenance of total glucose and lipid homeostasis. Adipocytes store excess calorie 
intake in the form of triacylglycerides (TAGs) to fuel the body by the process of 
lipolysis during fasting and energy deprivation. White adipose tissue is the primary 
site of energy storage and is the only organ evolved to do so, up to a certain limit, 
without losing its physiological properties. The metabolic direction of adipose tissue 
research has been extensively studied over the years and is reviewed in (Lafontan, 
2008).   
The fasted state 
Catecholamines are the main physiological activators of lipolysis by binding to the 
adrenergic receptors on the plasma membrane of the white adipocytes. Adrenergic 
receptors (ARs) are members of the family of G protein-coupled receptors (GPCRs). 
There are two α-AR (α1 and α2) and three β-AR (β1, β2, β3) subtypes of the receptors. 
All five adrenergic receptors are expressed in WAT. However, there are inter-depot 
(Mauriege et al., 1987; Arner et al., 1990) as well as inter-species (Lafontan et al., 
1995) differences in the presence of the receptor subtypes.  
Binding of catecholamines to β-adrenergic receptors activates adenylate cyclases 
(ACs), enzymes which catalyse the conversion of adenosine triphosphate (ATP) to 
cyclic adenosine monophosphate (cAMP). cAMP activates protein kinase A (PKA) 
and subsequently a set of different lipases that catabolize triacylglycerides into free 
fatty acids and glycerol that is released into the blood stream. Free fatty acids in the 
circulation are then taken up by peripheral tissues and β –oxidized to produce energy 
in the form of ATP (Arner, 1999; Duncan et al., 2007).  
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The fed state 
Insulin is secreted by pancreatic β-cells in response to elevations in blood glucose. 
Insulin switches metabolism from the catabolic to the anabolic state, and thus inhibits 
lipolysis and stimulates both glucose and free fatty acid uptake (Rutkowski et al., 
2015). Insulin binds to insulin receptors present on the adipocyte plasma membrane 
and activates insulin receptor substrate proteins that recruit phosphoinositide 3-kinase 
(PI3K) to the plasma membrane. PI3K phosphorylates and activates numerous 
proteins which ultimately leads to the activation of protein kinase B (PKB; also 
known as Akt) signaling pathway. Consequently, PKB phosphorylates and activates 
phosphodiesterase 3B (PDE3B), an enzyme that catalyses the hydrolysis of cAMP. In 
this way, cAMP-dependent activation of PKA and lipolysis is inhibited. PKB also 
stimulates the translocation of glucose transporter 4 containing vesicles to the plasma 
membrane, enabling the entry of glucose into the adipocyte (Taniguchi et al., 2006). 
Dietary fats or synthesised fatty acids from non-lipid substrates are the sources of 
fatty acids delivered to the white adipose tissue. The production of fatty acids from 
non-lipid substrates, de novo lipogenesis, mainly occurs in the liver even if WAT is 
also capable of this process. Fatty acids circulate in the form of triacylglycerides 
transported by lipoproteins. Lipoproteins are too large to penetrate the adipose tissue 
capillaries and triacylglycerides must therefore undergo lipoprotein lipase-dependent 
lipolysis before being delivered to the adipocytes as free fatty acids. Lipoprotein 
lipase is synthesised by the adipocytes and upregulated in the fed state. Once the free 
fatty acids are inside the adipocyte, they are re-esterified and stored in the lipid 
droplet as triacylglycerides (Ameer et al., 2014).  
 
Adipose tissue as an endocrine organ 
Over the last two decades, adipose tissue has been firmly established as an endocrine 
and highly complex organ. Adipose tissue can affect whole-body physiology in an 
auto-/para- and endocrine fashion by its wide range of secretory products. More than 
a hundred different biologically active molecules are secreted by WAT including 
hormone-like proteins, inflammatory cytokines, anti-inflammatory factors and sex 
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steroids (Kershaw & Flier, 2004; Fantuzzi, 2005; Balistreri et al., 2010). The 
peptides and proteins that are produced and released by adipose tissue are commonly 
referred to as adipokines.  
Adipokines have central as well as peripheral effects, and have gained a lot of 
attention due to their pleiotropic and important roles in inflammation, immunity, 
cardiovascular health and metabolism.  Some adipokines have gained increased 
attention due to their beneficial functions in obesity and obesity-related maladies 
(Ronti et al., 2006; Waki & Tontonoz, 2007; Balistreri et al., 2010). Adipocyte 
peptide and protein hormones include (but are not restricted to) leptin, adiponectin, 
adipsin, apelin and visfatin. Some of these adipocyte peptide hormones are further 
described below. 
The traditional view of white adipose tissue as a passive energy reservoir was revised 
with the discovery of the adipokine adipsin (also known as complement factor D) in 
1987 (Cook et al., 1987). Adipsin has recently been shown to be important for β-cell 
function and glucose homeostasis, and it has been reported that adipsin levels are 
decreased in type 2 diabetic patients (Lo et al., 2014). Moreover, adipsin has an 
important role in innate immunity and is crucial for complement activation by the 
alternative pathway (Xu et al., 2001).  
The endocrine role of adipose tissue was further confirmed with the discovery of 
leptin in 1994 (Zhang et al., 1994). Leptin is secreted by white adipocytes (also 
secreted by the gastric mucosa; Cammisotto & Bendayan, 2007) and leptin levels 
correlate with adipose tissue mass and are thus increased in obesity (Maffei et al., 
1995). Leptin is the most studied adipokine and has a central role in regulating food 
intake and energy expenditure by binding to leptin receptors in the brain to signal 
long-term satiety (Tartaglia et al., 1995). Moreover, leptin can indirectly affect 
glucose homeostasis by acting on the pancreatic β-cells to reduce insulin secretion 
(Marroqui et al., 2012). 
In 1995, Scherer and colleagues were the first to describe a novel protein highly 
specific to adipocytes which was later named adiponectin (Scherer et al., 1995). 
Shortly thereafter other groups reported the existence of adiponectin in adipocytes 
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from mouse and rat (Hu et al., 1996), in human plasma (Nakano et al., 1996) and in 
adipose tissue (K. Maeda et al., 1996). Since its discovery, adiponectin has shown 
great potential as an adipokine with anti-diabetic, anti-atherogenic and anti-
inflammatory properties. 
Adiponectin 
Adiponectin is a 30-kDA, 247 amino acid long peptide encoded by the AdipoQ gene 
(also called apM1, Acrp30). The production of adiponectin is regulated by 
adipogenetic transcriptional factors such as C/EBPs (Saito et al., 1999), sterol 
regulatory element binding protein 1c (Seo et al., 2004) and peroxisome proliferator 
activated receptor gamma (PPARγ; N. Maeda et al., 2001). 
Adiponectin (Fig. 3) consists of an N-terminal 
signalling peptide region followed by a collagenous 
domain and a C-terminal globular domain (Scherer et 
al., 1995). Full-length adiponectin is present in the 
circulation as a low molecular weight (LMW) trimer, 
hexamer or a high molecular weight (HMW) multimer 
complex (Tsao et al., 2003). After synthesis in the 
endoplasmic reticulum (ER), the assembly of different 
adiponectin isoforms is tightly regulated and 
dependent on the ER-chaperones ERp44 and Ero1-Lα 
(Z. V. Wang et al., 2007; Hampe et al., 2015). Multimerisation of full-length 
adiponectin to higher order complexes requires extensive post-translational 
modifications (Y. Wang et al., 2006) and once secreted the complexes stay stable and 
do not inter-convert between different forms (Schraw et al., 2008). In humans and 
rodents, the HMW to LMW ratio as well as total adiponectin levels are higher in 
females than in males (Pajvani et al., 2003; Gui et al., 2004; Santaniemi et al., 2006). 
Adiponectin is produced and secreted by mature adipocytes. Adiponectin is highly 
abundant in blood (mg/l range) and accounts for ~0.01% of total serum protein in 
humans (Arita et al., 1999). The half-life of adiponectin in humans has not been 
determined but the half-life of human adiponectin in rabbits is reported to be 14.3 h 
 
Fig. 3 Adiponectin 
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and 17.5 h for the LMW and HMW, respectively (Peake et al., 2005). In another 
study, wild-type and recombinant adiponectin had a half-life of ~75 min in mice and 
differences in clearance rates for the different isoforms were also reported (Halberg 
et al., 2009).  
Although adiponectin expression has also been detected in skeletal muscle, 
endothelial cells and cardiac myocytes (Delaigle et al., 2004; Pineiro et al., 2005; 
Wolf et al., 2006) the contribution by these alternative sources to circulating levels is 
uncertain. In context, mice lacking adipose tissue do not exhibit significant plasma 
levels of adiponectin pinpointing the adipose tissue as the main source of adiponectin 
(F. Wang et al., 2013). 
Metabolic effects of adiponectin 
Most studies investigating the mechanisms mediating the metabolic effects of 
adiponectin are conducted using different animal or in vitro models. Those 
investigations therefore chiefly use in vitro produced full-length adiponectin or its 
cleaved globular form. The physiological significance of globular adiponectin has 
been debated as mainly full-length adiponectin multimers are released into 
circulation. Nevertheless, studies of this kind have provided some insight into the 
important role of adiponectin in the regulation of whole body physiology. 
The two main receptors by which adiponectin mediate its effects are AdipoR1 and 
AdipoR2 (Yamauchi et al., 2003; Yamauchi et al., 2007). AdipoR1 is predominantly 
present in skeletal muscle and has a higher affinity for the globular domain of 
adiponectin whereas AdipoR2 is highly expressed in the liver and has a higher 
affinity for the full-length protein (Yamauchi et al., 2003). Adiponectin receptors are 
widely distributed and have, in addition to skeletal muscle and liver, been shown to 
be present in adipose tissue (Rasmussen et al., 2006), heart (Ding et al., 2007; 
Palanivel et al., 2007), pancreas (Staiger et al., 2005) and in the brain (Kubota et al., 
2007).  
Increased plasma triglyceride levels, hyperglycemia and insulin resistance are all 
symptoms of the metabolic syndrome, prediabetes or type 2 diabetes (Grundy, 2012). 
Combined results of several studies indicate that adiponectin has great potential to 
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improve many of these pathological conditions. Skeletal muscle, which is the body’s 
major source of glucose uptake, is highly affected by obesity and insulin resistance in 
this tissue is itself a contributor to type 2 diabetes (DeFronzo & Tripathy, 2009). 
Skeletal muscle benefits from adiponectin in several ways. Adiponectin acts on 
skeletal muscle to increase free fatty acid oxidation (Fruebis et al., 2001; Yamauchi 
et al., 2002), glucose uptake (Ceddia et al., 2005) and mitochondrial number and 
function (Ceddia et al., 2005). Insulin acts on the liver to inhibit glucose output; an 
insulin resistant liver will itself contribute to increased blood glucose levels 
(Titchenell et al., 2015). Adiponectin decreases liver glucose output by increasing 
liver insulin sensitivity and by suppressing genes involved in gluconeogenesis (Berg 
et al., 2001; Combs et al., 2001; Yamauchi et al., 2002; Miller et al., 2011). 
There are several proposed roles of adiponectin in inflammation. Adiponectin has 
been shown to down-regulate macrophage recruitment to the inflammatory tissue and 
decrease the production of pro-inflammatory cytokines such as TNF-α and 
interleukin 6 (Yokota et al., 2000; Park et al., 2008). Adiponectin can also inhibit the 
expression of TNF-α in the liver and by autocrine effects in the adipocytes (A. Xu et 
al., 2003; Ajuwon & Spurlock, 2005). Furthermore, adiponectin can increase the 
production of anti-inflammatory cytokines in leukocytes, monocytes and 
macrophages (Kumada et al., 2004; Wolf et al., 2004; Wulster-Radcliffe et al., 
2004).  
The role of adiponectin in the central nervous system is not fully understood. 
AdipoR1 and AdipoR2 are expressed in the hypothalamus of rodents (Kubota et al., 
2007; Guillod-Maximin et al., 2009) and humans (Kos et al., 2007).  Adiponectin has 
also been detected in rodent (Kubota et al., 2007) and human (Kos et al., 2007; 
Kusminski et al., 2007) cerebrospinal fluid. On the contrary, in a previous study 
adiponectin was not detectable in human cerebrospinal fluid and it did not pass the 
blood brain barrier (Spranger et al., 2006).  
Disturbed adiponectin levels in obesity and type 2 diabetes 
Low adiponectin levels are now established as a marker of the metabolic syndrome 
(Ryo et al., 2004). Unlike most adipokines adiponectin levels decrease in the obese 
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state, a correlation demonstrated in several studies (Hu et al., 1996; Arita et al., 1999; 
Weyer et al., 2001). Associations have also been observed between adiponectin and 
different adipose tissue depots where adiponectin levels exhibit an independent 
negative correlation to visceral fat mass (Gavrila et al., 2003; Lihn et al., 2004; Cote 
et al., 2005). Moreover, visceral adipocyte size negatively correlates with serum 
HMW adiponectin (Meyer et al., 2013).  
Reduced production and plasma levels of adiponectin are closely linked to insulin 
resistance (Weyer et al., 2001) and low levels of adiponectin (hypoadiponectinemia) 
correlate better with insulin resistance than with adiposity (Hotta et al., 2000; Weyer 
et al., 2001; Kloting et al., 2010). Furthermore, several studies implicate low levels 
of HMW rather than total levels of adiponectin as a predictor of the development of 
type 2 diabetes (Pajvani et al., 2004; Murdolo et al., 2009).  
Chronic inflammation in the white adipose tissue has been suggested to play a causal 
role in the development of insulin resistance and type 2 diabetes (Hotamisligil, 
2006). Previous studies have shown an inverse correlation between the inflammatory 
cytokine TNF- α and adiponectin levels (Kern et al., 2003; Hector et al., 2007). In a 
recent study in mice TNF- α was shown to decrease HMW adiponectin but not LMW 
adiponectin (He et al., 2015).  
In obesity, impaired vascularisation to cope with the demand of expanded adipocytes 
might lead to hypoxia (Kabon et al., 2004; Spencer et al., 2011). Studies in 3T3-L1 
as well as human cultured adipocytes have shown diminished adiponectin expression 
and secretion under hypoxic conditions (Chen et al., 2006; B. Wang et al., 2007). 
Regulation of adiponectin expression and secretion 
A few studies have shown adiponectin gene expression to be downregulated during 
continuous exposure to β-AR- or cAMP-agonists (Fasshauer et al., 2001; Delporte et 
al., 2002; Cong et al., 2007; Fu et al., 2007). In one of the first studies that 
investigated the effect of adrenergic exposure on adiponectin secretion, 10 hour 
incubations of visceral adipose tissue explants with a β3-AR- or cAMP-agonist 
decreased adiponectin secretion (Delporte et al., 2002). The β-AR-induced 
suppression of adiponectin expression in 3T3-L1 adipocytes was further shown to be 
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mediated by PKA (Fasshauer et al., 2001). Similar observations have been reported 
in primary rat adipocytes exposed to the β-AR agonist isoprenaline. In these 
experiments, 24 hour exposure to isoprenaline inhibited adiponectin secretion in a 
dose-dependent manner while stimulating lipolysis (Cong et al., 2007). The 
inhibiting effect of isoprenaline on adiponectin secretion was shown after 4 hours of 
treatment and could be reversed when adipocytes were exposed to insulin in 
combination with the β-AR agonist. Furthermore, the reversing effect of insulin on 
isoprenaline-suppressed adiponectin secretion was shown to be mediated by a PI3K-
mediated breakdown of PDEs (Cong et al., 2007). PDE3B activation has previously 
been shown to be PI3K-dependent and is the basis for the opposing effects of cAMP-
increasing β-AR-agonists and insulin (Degerman et al., 1996). 
On the gene level, insulin has been shown to decrease (Fasshauer et al., 2002), 
increase (Halleux et al., 2001; Seo et al., 2004; Cong et al., 2007) or to have no 
effect (Pereira & Draznin, 2005; Li et al., 2013) on adiponectin expression. These 
disparities might be explained by different experimental conditions as well as 
variances in the adipocyte source (different animal species and/or adipose depot or 
cultured adipocytes). More consistently, several investigations have shown an 
insulin-mediated stimulation of adiponectin secretion at time points ranging from 
half an hour up to 24 hours (Bogan & Lodish, 1999; Motoshima et al., 2002; Pereira 
& Draznin, 2005; Cong et al., 2007; Blümer et al., 2008; Li et al., 2013; Lim et al., 
2015). The stimulatory effect of insulin on adiponectin secretion has further been 
shown to be mediated via PI3K (Pereira & Draznin, 2005; Blümer et al., 2008; Lim 
et al., 2015) and inhibition of this pathway also downregulated adiponectin gene 
expression (Pereira & Draznin, 2005).  
Already in the first study identifying adiponectin in 1995, Scherer and colleagues 
suggested that the adipokine is secreted via regulated exocytosis (Scherer et al., 
1995). Further studies reported the presence of a secretory compartment containing 
adiponectin and that short-term secretion of adiponectin (measurable elevated release 
after 30-60 min) could be stimulated by insulin (Bogan & Lodish, 1999; Lim et al., 
2015). The location of adiponectin in close vicinity to the plasma membrane has also 
been reported in human adipocytes (Halleux et al., 2001). Adiponectin has also been 
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proposed to be secreted by endosomal pathways (Clarke et al., 2006; Xie et al., 2006; 
Xie et al., 2008). However, inhibition of the endosomal pathway/ER-Golgi transport 
vesicles has been shown to only partially block adiponectin secretion, indicating that 
the release of adiponectin involves other secretory pathways (Xie et al., 2008). In 
conclusion, while the long-term regulation of adiponectin secretion has been 
investigated to some extent, there is surprisingly little known about the short-term 
regulation of adiponectin exocytosis 
Exocytosis 
Exocytosis is an essential biological process in all eukaryotic cells and enables 
normal cellular function and intercellular communication by the release of secretory 
factors. Synthesised proteins in the ER pass the Golgi complex and continue to trans-
Golgi where they are packed in vesicles destined for secretion. In constitutive 
exocytosis, secretory vesicles containing peptides or lipids produced by the cell can 
be released by spontaneous fusion with the plasma membrane. Most neuroendocrine 
and endocrine cells also have a pathway of regulated exocytosis, where secretory 
vesicles accumulate in the cytoplasm and undergo fusion with the plasma membrane 
only upon a triggering signal (Burgoyne & Morgan, 2003) in a process termed 
stimulus-secretion coupling. The terminology was first described in 1962, where 
Douglas & Poisner showed that the trigger of catecholamine release from chromaffin 
cells was due to Ca2+ influx stimulated by extracellular acetylcholine (Douglas & 
Poisner, 1962). Since then, biophysical methods such as patch-clamp capacitance 
measurements and optical methods such as total internal reflection fluorescence 
(TIRF) microscopy has enabled single cell studies of high temporal and spatial 
resolution, allowing researchers to investigate properties and kinetics of regulated 
vesicle release (Neher & Marty, 1982; Steyer et al., 1997). Combined, studies in 
different (neuro)endocrine cell types have led to a rather unified model of the 
different steps controlling regulated exocytosis (Burgoyne & Morgan, 2003). 
Stimulus-secretion coupling in neuroendocrine and 
endocrine cells 
Secretory vesicles are divided into different functional pools depending on their 
release competence. A distinction is made between mature vesicles belonging to a 
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readily releasable pool and immature vesicles belonging to a reserve pool. Readily 
releasable vesicles can be released directly upon a physiological stimulus. Once the 
readily releasable pool is depleted, vesicles from the reserve pool need to undergo 
different functional modifications and/or physical translocation to the plasma 
membrane in order to be release competent (Burgoyne & Morgan, 2003).  
In most endocrine cell types, Ca2+ is the primary signal that triggers the fusion of 
readily releasable vesicles with the plasma membrane (Burgoyne & Morgan, 2003). 
Ca2+ sources include influx via voltage-gated Ca2+ channels and/or release from 
intracellular Ca2+ stores. Release-ready vesicles can be localised close to Ca2+ 
channels, which upon activation expose the vesicles to high local concentrations of 
Ca2+ and rapid release (Moser & Neher, 1997; Wiser et al., 1999; Barg et al., 2001; 
Becherer et al., 2003). Ultimate fusion of secretory vesicles with the plasma 
membrane involves a complex interplay between several vesicle- and plasma 
membrane bound proteins termed SNAREs (soluble N-ethylmaleimide-sensitive 
factor attachment protein receptor proteins; Sudhof & Rothman, 2009; Hong & Lev, 
2014). Upon Ca2+ stimulus and activation of vesicular Ca2+ sensors, release-ready 
vesicles will be tightened to the plasma membrane by the SNAREs in a zipper-like 
fashion for ultimate fusion. The conformational changes that occur during the 
assembly of the SNAREs are thought to provide the energy required for fusion with 
the plasma membranes (Sudhof & Rizo, 2011; Hong & Lev, 2014). Vesicles that 
interact with the plasma membrane but are too far away from the SNAREs to 
assemble are referred to as tethered vesicles, whereas docked vesicles are stationary 
and morphologically connected to the plasma membrane (Lang et al., 2001; de Wit, 
2010). Recent studies have shown that not all vesicles require docking prior to Ca2+-
dependent exocytosis (Allersma et al., 2004; Toonen et al., 2006; Shibasaki et al., 
2007; Kasai et al., 2008). Besides triggering vesicle fusion, Ca2+ has also been shown 
to be involved in the physical translocation and docking of vesicles  (Becherer et al., 
2003). The mechanisms mediating the physical docking of vesicles are not 
completely understood but seem to involve several exocytotic protein complexes (de 
Wit, 2010). In order to gain release-competence and refill the readily releasable pool, 
docked vesicles need to undergo Ca2+-, ATP-, cAMP-, time- and temperature-
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dependent modifications referred to as priming (Parsons et al., 1995; Eliasson et al., 
1997; Renstrom et al., 1997). This was first described in chromaffin cells where 
Ca2+-stimulated secretion in the absence of Mg-ATP occurred only for a short time, 
and where Mg-ATP only could potentiate secretion only if it preceded Ca2+-
stimulation (R. W. Holz et al., 1989). In later studies conducted by the same group 
ATP-dependent priming was shown to be stimulated by low intracellular Ca2+ levels, 
and to be proceeded by a later rate-limiting temperature-dependent step (Bittner & 
Holz, 1992a, 1992b). Similarly, ATP has been shown to be required for sustained 
exocytosis and refilling of the readily releasable pool of vesicles in β-cells (Eliasson 
et al., 1997). Moreover, a decrease in temperature inhibited the refilling of the readily 
releasable pool but did not alter Ca2+-stimulated exocytosis of mature vesicles, 
indicating that vesicle replenishment is an energy-dependent process (Renstrom et 
al., 1996).  
cAMP-dependent exocytosis 
Intracellular cAMP levels are elevated by various GPCRs and cAMP is a well-known 
modulator of regulated exocytosis in many secretory cell types. cAMP mediates its 
actions in several ways involving activation of PKA, exchange proteins directly 
activated by cAMP (Epac) and/or cyclic nucleotide-gated ion channels (Seino & 
Shibasaki, 2005).  
The PKA-mediated actions of cAMP can be due to phosphorylation of one or several 
target proteins and have in numerous cell types been shown to be involved in 
modulations of the vesicle pools rather than in the release process. These effects 
include increases in vesicle size due to pre-exocytotic vesicle-vesicle fusion (Sikdar 
et al., 1998; Carabelli et al., 2003) and acceleration of vesicle replenishment of the 
readily releasable pool (Ammala et al., 1993; Renstrom et al., 1997; Nagy et al., 
2004). Part of the PKA-mediated effect can also be due to an amplification of the 
Ca2+ signal such as increased Ca2+ influx by a direct effect on voltage-gated Ca2+ 
channels (Ammala et al., 1993; Carabelli et al., 2003; Calejo et al., 2014), Ca2+ 
release from intracellular Ca2+ stores (Sedej et al., 2005) or by sensitizing certain 
vesicle pools to Ca2+ (Wan et al., 2004; Skelin & Rupnik, 2011). 
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The role of Epac in the regulation of exocytosis has become increasingly attended to 
in search of the missing links of cAMP-dependent exocytosis. Epac is a cAMP 
activated guanine nucleotide exchange factor (cAMP-GEF) and its two isoforms, 
Epac1 and Epac2, are present in most tissues at various levels (Schmidt et al., 2013). 
GEFs activate small GTPases by catalysing the release of guanosine diphosphate 
(GDP) and binding of guanosine triphosphate (GTP). Epac can activate several small 
GTPases of the Ras superfamily (Schmidt et al., 2013) and the activation of small 
GTPases of the Ras and Rab family has been shown to be involved in several 
exocytotic processes (G. G. Holz et al., 2006). 
Before the discovery of Epac, a PKA-independent role for potentiation of Ca2+-
stimulated exocytosis was shown in β-cells (Renstrom et al., 1997). It has later been 
shown that Epac facilitates the priming of vesicles (Eliasson et al., 2003) but that it 
also regulates rapid exocytosis of GABA containing synaptic like vesicles that are 
also secreted by the β-cell (Hatakeyama et al., 2007). Moreover, Epac2 has also been 
shown to be important for cAMP-induced potentiation of first phase insulin secretion 
as part of this potentiation was diminished in Rap1 knockdown cells (Shibasaki et al., 
2007). The involvement of Epac1 has previously been reported in non-endocrine cell 
exocytosis. In the exocrine parotid acinar cells, amylase release was shown to be 
partially mediated by PKA-independent pathways involving Epac1. Furthermore, 
Epac1 was shown to be present on vesicle membranes and on the plasma membrane 
(Shimomura et al., 2004). In the sperm acrosomal reaction, Epac1 is crucial for 
assembly of the fusion machinery and mobilisation of Ca2+ from intracellular stores, 
ultimately leading to acrosome exocytosis (Branham et al., 2009; Ruete et al., 2014).  
As the activation of different GPCRs can result in different physiological outcomes 
the importance of GPCR-mediated local regulation of cAMP is evident. cAMP 
signalling has been shown to be compartmentalised and thus concentrated to specific 
regions within cells. Compartmentalised signaling can be obtained by differential 
distribution of diverse ACs or PDEs allowing establishment of cAMP gradients 
(Cooper, 2003; Houslay & Adams, 2003). In this way, different cAMP 
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concentrations achieved at distinct cellular locations can differentially regulate 
specific intracellular actions.  
 
  
 | Aims 17 
 
Aims 
The overall aim of this thesis was to investigate the mechanisms and mediators 
regulating white adipocyte exocytosis and short-term adiponectin secretion.  
The specific aims were to: 
 
1) Investigate the role of the intracellular mediators Ca2+, cAMP and ATP in 
white adipocyte exocytosis and short-term adiponectin secretion. 
 
2) Explore the temperature/energy-dependency of white adipocyte exocytosis 
and adiponectin secretion. 
 
3) Determine the physiological regulation of adiponectin exocytosis and how 
this regulation might be disturbed in obesity and type 2 diabetes. 
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Methodology 
The reader is referred to paper I-III in this thesis for detailed protocols for the 
methods described in this section. 
3T3-L1 adipocytes 
3T3-L1 adipocytes are an established in vitro adipocyte model and widely used in 
studies of adipocyte differentiation, gene expression and adipokine secretion (Scherer 
et al., 1995; Fasshauer et al., 2001; Rosen & MacDougald, 2006). The 3T3-L1 
preadipocyte cell line is of murine origin and was isolated and cloned 1974 (Green & 
Meuth, 1974). 3T3-L1 preadipocytes can be differentiated to mature adipocytes by 
the addition of a differentiation mix consisting of insulin, dexamethasone (dexa) and 
3-isobutyl-1-metylxantine (IBMX). The differentiation mix induces several 
adipogenetic processes (Rosen & MacDougald, 2006; Petersen et al., 2008) including 
activation of transcriptional activator CREB which induces expression of PPARγ, 
C/EBPα and C/EBPβ. The precise mechanisms of adipocyte differentiation are still 
being elucidated. Our protocol is based on (Kohn et al., 1996) and summarized 
below. 
American Type Culture Collection (ATCC) 3T3-L1 adipocytes were cultured in 
tissue culture flasks and incubated at 37°C and 5% CO2 together with high-glucose 
DMEM containing 1% penicillin-streptomycin and 10% newborn calf serum. At 80% 
confluency, cells were split from flasks and seeded to plastic or glass-bottom 35 mm 
dishes or multi-well plates. Cells were then grown to high confluency before the 
differentiation mix was added (day 0; Fig. 4). The differentiation mix consisted of 
1 µM dexa, 0.5 mM IBMX and 850 nM insulin in DMEM. After 48 hours the 
differentiation medium was replaced with medium containing only insulin (day 2). 
The medium was thereafter replaced every second day, and experiments were 
conducted between day 8-10 after start of differentiation (Fig. 4). 
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Fig. 4 3T3-L1 preadipocytes in the fibroblast-like state before differentiation (left) and 
differentiated mature adipocytes (right). Scale bar = 50 μM 
Isolation of primary adipocytes 
Human adipocytes were isolated from subcutaneous tissue biopsies (paper I). Mouse 
inguinal adipose tissue was isolated from C57BL/6J wild type mice (paper III). 
Briefly, adipose tissue was minced down and degraded using collagenase. The 
floating adipocytes were then washed and poured through a nylon mesh to isolate 
adipocytes in a 50 ml tube. The washing step was repeated twice. Human cells were 
incubated overnight before adiponectin secretion measurements were performed 
(paper I). Mouse adipocytes were either directly used for adipokine secretion 
measurements or frozen at -80°C for gene expression analysis. 
Adipokine secretion in 3T3-L1 adipocytes 
3T3-L1 adipocytes seeded and differentiated on multi-well plates were washed and 
preincubated for 30 min with glucose-free extracellular solution (EC), in the presence 
or absence of specified stimulatory/inhibitory agents. The preincubation solution was 
then replaced with EC containing 5 mM glucose together with test substances. Cells 
were incubated for 30 min with gentle shaking at 32°C or at indicated temperature. 
At the end of the incubation, the supernatant was collected and centrifuged 
(2000 rpm, 5 min) to remove non-adherent cells. The adherent cells were washed and 
lysed in the presence of a protease inhibitor. All samples were aliquoted and stored at 
-80°C for further analysis. Secreted adipokines were measured by ELISA and protein 
content with Pierce BCA protein kit or Bradford protein assay, according to 
manufacturer’s instructions. 
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Patch-clamp 
The patch-clamp technique is a powerful method for studying the 
electrophysiological properties of live single cells. The method was developed by 
Erwin Neher and Bert Sakmann for which they won the Nobel Prize in Physiology or 
Medicine in 1991 (Neher et al., 1978).  
The patch-clamp method can be used to measure the electrical properties over a small 
membrane patch or over the entire cell membrane. A fire-polished glass pipette is 
backfilled with an intracellular solution and mounted on an electrode connected to an 
amplifier. A cell attached to the bottom of a dish is coupled to the electrical circuit by 
formation of tight seal between the glass pipette and the cell. The seal has a high 
electrical resistance (typically >1 GΩ) and is called a “giga-seal”. The cell dish is 
continuously perfused with an extracellular solution and a constant temperature is 
maintained by a feedback temperature controller. A reference electrode is situated in 
the cell bath to complete the electrical circuit. 
To obtain an electrical circuit and enable measurements of electrical properties over 
the entire cell membrane it is necessary to gain access to the cell cytosol. This can be 
done in two ways. In the perforated-patch whole-cell configuration, access to the 
cytosol is gained by using a membrane pore-forming antibiotic included in the 
pipette solution. The pores formed are only large enough to permit the flow of 
monovalent ions and the intracellular environment remains rather intact. To gain full 
access to the cell interior, gentle suction can be applied to rupture the enclosed 
membrane to obtain the standard whole-cell configuration (Hamill et al., 1981). This 
configuration has the advantage of permitting control of the intracellular milieu by 
wash-in of the pipette solution including substances of interest. The standard whole-
cell configuration allows application of ions, molecules such as cAMP and ATP, 
membrane impermeable agonists/antagonist, antibodies etc. to the inside of the cell.  
The electrical recordings can be measured in the current-clamp mode or the voltage-
clamp mode. In the current-clamp mode, a current is injected by the amplifier 
through the microelectrode and the membrane potential is measured. In the voltage-
clamp mode cells are instead clamped at a specific holding potential to measure the 
22 Ali Komai|  
 
currents. To clamp the membrane potential, any activated currents in this mode are 
compensated by a negative feedback mechanism; the amplifier injects currents of the 
opposite sign of that registered from the cell. The voltage-clamp mode further allows 
recordings of exocytotic events measured as increases in membrane capacitance, the 
type of electrophysiological recordings applied in this thesis. 
The patch-clamp recordings in this thesis were conducted with a HEKA amplifier 
(EPC9) and PatchMaster software. 
 
Fig. 5 A simplified representation of a patch-clamp circuit in the standard whole-cell 
configuration. Access to the cytosol is gained by disruption of the membrane enclosed by the 
pipette to allow wash in of the pipette solution. An electrical circuit is completed by the pipette 
electrode and the reference (bath) electrode. In the voltage-clamp mode the cell is clamped at a 
specific membrane potential and the sum of membrane currents or capacitance (Cm) can be 
measured. Rm represents the membrane resistance.  
Capacitance measurements 
Patch-clamp capacitance measurements allow online registrations of exocytosis 
measured as the increase in plasma membrane area that arises when secretory 
vesicles fuses with it (Neher & Marty, 1982). All biological membranes act as 
capacitors and the specific capacitance of biological membranes is estimated to be 
10fF/μm2 (Hille 1992).  
Capacitance (Cm; Farad) is measured by the equation: 𝐶𝑚 =  𝐴·ε𝑑  
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where A denotes the membrane area, ε is the specific membrane capacitance and d is 
the membrane thickness. The thickness of the phospholipid bilayer (d) and ε are 
constant. Thus, the capacitance is proportional to the membrane area. In exocytosis, 
the membrane of the secretory vesicle is fused with the plasma membrane of the cell 
to enable release of the vesicle content. The fusion of the vesicle membrane with the 
plasma membrane results in an increase in the membrane surface area and can thus 
be measured as an increase in capacitance.  
The most commonly used method to measure alterations of membrane capacitance 
employs a sine wave voltage stimulus. The amplitude and phase of the resulting 
sinusoidal current can be resolved using a phase-sensitive detector which is 
implemented in the software or hardware using a lock-in amplifier.  
In this thesis, exocytotic events were instead registered as repetitive Auto C-slow 
compensations using the CapTrack function of PatchMaster. This procedure applies 
short trains of square-wave pulses, averages the resulting currents and fits an 
exponential to deduce the compensation values needed to cancel the current. The 
number of currents as well as their amplitude can be varied. Here we have applied a 
train of 10 pulses with an amplitude of 5 mV. 
Fluorescence microscopy 
Fluorescence is the outcome of a process where light of a definite wavelength is 
absorbed by specific molecules called fluorophores or fluorescent dyes. The 
absorption is followed by emission of light at longer wavelengths.  
In this thesis alterations in intracellular concentrations of Ca2+ ([Ca2+]i) were 
measured by dual-wavelength ratiometric Ca2+ imaging. Cells were loaded with the 
membrane-permeable fluorescent Ca2+ dye fura-2 AM (2 µM) together with 0.02% 
(wt/vol) Pluronic to facilitate the solubilization of fura-2 AM. The excitation 
wavelength for fura-2 differs depending on if the dye is bound to Ca2+ or not.  The 
Ca2+ unbound form of fura-2 has its excitation maximum at 380 nm and the Ca2+ 
bound form at 340 nm. The emitted light is collected at 510 nM. With elevated 
[Ca2+]i the fluorescence intensity increases at 340 nm while fluorescence decreases at 
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380 nm for the unbound form. This thus gives a ratio between the Ca2+-bound and 
unbound state of fura-2. Ratiometric measurements have the advantage of 
eliminating inter-experiment variations in dye loading and declining fluorescence due 
to photobleaching. We employed a Lambda DG-4 illumination system (Sutter 
Instrument Company, USA) combined with a Nikon Diaphot 300 inverted 
microscope (Nikon, Japan) and a QuantEM 512SC CCD camera (Photometrics, 
USA). Metafluor software was used. The [Ca2+]i was calculated using the equation 5 
of (Grynkiewicz et al., 1985) and a Kd of 224 nM. 
Total internal reflection (TIRF) microcopy is an advanced imaging technique that 
allows visual investigations of events only in the plasma membrane near region 
(approx. 100-200 nm beneath the plasma membrane; Burchfield et al., 2010). Here 
we have used a Zeiss TIRF 3 microscope equipped with a Plan-Apochromat 
objective (100x/1,46 Oil) and a back-illuminated EMCCD digital camera (Evolve 
512 Delta, Photometrics).  
Quantitative RT-PCR 
Real-Time quantitative reverse transcription polymerase chain reaction (Real-Time 
qRT-PCR) allows the analysis of nucleic acids in a variety of biological applications 
such as gene expression studies. The technique requires RNA or mRNA to be 
transcribed to complementary DNA (cDNA) using an enzymatic reaction by reverse 
transcriptase. In brief, the RNA of interest is chemically extracted and the purity is 
validated spectrophotometrically by measuring absorbance at 260 and 280 nm. The 
RNA is then transcribed to its complementary DNA (cDNA) which is the starting 
material for amplification analysis by thermo cyclers. Amplifications of specific 
cDNA sequences (amplicon) can be detected due to the presence of fluorescently 
labelled primers or probes. We have used the fluorescent probe SYBR green which 
interchelates into newly synthesised double-stranded DNA. The amount of produced 
amplicon is proportionally correlated with fluorescence produced over time and 
detected by the cycler. The threshold cycle (Ct value) at which the amplicon is 
detected during the exponential phase of amplification is inversely proportional to the 
relative expression of the target gene. Relative gene expression can be determined by 
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normalising the Ct value of the gene of interest to the Ct value of a reference gene 
known to be stably expressed in the samples.  
 
Data analysis 
The exocytotic rates (ΔCm/Δt; fF/s) were measured by application of linear fits to the 
capacitance trace at the different indicated time points (Fig. 6). The total capacitance 
increase reflecting total amount of exocytosis was measured from the initial 
capacitance value until the end of capacitance increase (plateau) where no further 
exocytosis was observed, or at indicated time point. Average ΔCm/Δt or the total 
capacitance increase was compared for different series of experiments and 
statistical significance was calculated using unpaired Student’s t-test. Free [Ca2+] for 
the pipette solution was calculated using MAXCHELATOR downloads 
(http://www.stanford.edu/patton/maxc.html).  
 
Fig. 6 Example trace with the difference in capacitance (ΔCm)  plotted against time. The rate of 
exocytosis (ΔCm/Δt)  was measured at different time intervals (dotted lines) by application of 
linear fits (grey) to the indicated data points in the capacitance trace (black). 
All data are presented as mean values ± SEM. Statistical significance between means 
was calculated using OriginPro (OriginLab Corporation, USA) and Student’s t-test, 
unpaired or paired as appropriate. One-way ANOVA was applied where more than 
one group is compared to the same control group.  
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Results and discussion 
PKA-independent cAMP stimulation of white 
adipocyte exocytosis and adipokine secretion: 
modulations by Ca2+ and ATP (Paper I) 
The first paper published on adiponectin 20 years ago suggested the existence of a 
pool of secretory vesicles containing adiponectin (Scherer et al., 1995). Several 
investigations have since then been carried out with the aim to elucidate the 
regulation of adiponectin secretion (Bogan & Lodish, 1999; Halleux et al., 2001; 
Delporte et al., 2002; Motoshima et al., 2002; Pereira & Draznin, 2005; Cong et al., 
2007; Blümer et al., 2008; Xie et al., 2008). However, the majority of those studies 
have investigated adiponectin secretion during longer time-periods of hours or days. 
Thus, the mechanisms controlling adiponectin exocytosis are inadequately 
investigated. Since the introduction of membrane capacitance measurements three 
decades ago (Neher & Marty, 1982) single cell investigations with high temporal 
resolution has led to great strides in the research field of regulated exocytosis. 
However, there are only a handful of studies where the patch-clamp technique has 
been applied to white adipocytes (Ramirez-Ponce et al., 1990; Ramirez-Ponce et al., 
1991; Ramirez-Ponce et al., 1996; Lee & Pappone, 1997; Ramirez-Ponce et al., 
1998; Sukumar et al., 2012; Bentley et al., 2014), perhaps due to the methodological 
complexity combined with the ungainly shape and size of adipocytes. The 
intracellular messengers Ca2+, cAMP and ATP are involved in control of regulated 
exocytosis in a number of known neuroendocrine and endocrine cell types (Burgoyne 
& Morgan, 2003). In this study we define the mechanisms controlling exocytosis and 
adipokine secretion in white adipocytes using a combination of membrane 
capacitance recordings and biochemical measurements of released adipokines. 
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The role of cAMP in white adipocyte exocytosis and 
adipokine secretion 
3T3-L1 adipocyte exocytosis is stimulated by cAMP 
Being an endocrine cell, white adipocyte exocytosis was hypothesised to be regulated 
similarly to how exocytosis is regulated in other (neuro)endocrine cell types. To 
investigate the mechanisms and mediators involved in stimulation of adipocyte 
exocytosis, we infused cells with a pipette solution containing a high concentration of 
Ca2+ (9 mM CaCl2 buffered with 10 mM EGTA resulting in a free [Ca2+] of 
~1.5 µM) together with 0.1 mM cAMP and 3 mM ATP. This composition of 
intracellular solution has previously been shown to potently stimulate exocytosis in 
the pancreatic β-cell (Barg et al., 2002; Olofsson et al., 2009) and in chromaffin cells 
(Neher & Augustine, 1992). As shown in Fig. 7 the solution stimulated exocytosis 
and the exocytotic rate (ΔCm/Δt) measured during the second minute after entering 
the whole-cell configuration averaged ~25 fF/s. It is interesting that similar rates of 
exocytosis have been reported in β-cells (~30-40 fF/s) (Proks et al., 1996; Barg et al., 
2002; Olofsson et al., 2009) despite the ~10-fold larger size of adipocytes. This may 
indicate that the large size of adipocytes is more related to their role as lipid storing 
cells than to their endocrine function. 
We next infused cells with the same solution lacking cAMP. Interestingly, exocytosis 
could not be triggered when cAMP was omitted from the pipette solution although 






Fig. 7 Adipocyte exocytosis is 
triggered by cAMP. 
Representative capacitance 
traces of cells infused with 
1.5 μM free Ca2+ and 3 mM 
ATP, in the presence or 
absence of 0.1 mM cAMP. 
 
 | Results and discussion 29 
 
To investigate if cAMP could stimulate exocytosis under Ca2+-free conditions we 
included cAMP together with the fast Ca2+ chelator BAPTA (10 mM) in the pipette 
solution (ATP still present). Indeed, cAMP alone was capable of triggering 
exocytosis, although at a ~40%   lower rate compared to in the presence of Ca2+ 
(measured during the 2nd minute of infusion). 
We thus concluded that adipocyte exocytosis can be triggered by cAMP in a Ca2+-
independent manner. The observation that cAMP can stimulate exocytosis under 
Ca2+-free conditions and that Ca2+ alone was not sufficient to trigger exocytosis show 
that white adipocyte exocytosis is regulated in a way quite different from how 
endocrine cell exocytosis is usually controlled. 
cAMP-stimulated exocytosis correlates with adiponectin secretion in 
3T3-L1 and primary human subcutaneous adipocytes 
Capacitance measurements provide mechanistic information of vesicle fusion with 
the plasma membrane but give no information about the secretory product. We thus 
investigated if elevated cAMP levels were able to stimulate the secretion of 
adiponectin, adipsin, apelin, leptin or resistin, all adipocyte peptide/protein hormones 
suggested to be released by regulated exocytosis (Bogan & Lodish, 1999; Bradley & 
Cheatham, 1999; Roh et al., 2000; Zhong et al., 2002; Xie et al., 2008; Ye et al., 
2010). Adipokine levels were analysed in medium from adipocytes incubated for 30 
min in the presence of cAMP-elevating agents. The incubation time was short 
enough for correlations with capacitance measurements, yet long enough to allow for 
measurable adipokine levels. We used the AC activator forskolin in combination 
with the PDE inhibitor 3-Isobutyl-1-methylxanthine (forsk-IBMX) to elevate 
intracellular cAMP levels. An elevation of cAMP stimulated adiponectin secretion 
>3-fold compared to control (the same solution lacking forsk-IBMX). Forsk-IBMX 
did not stimulate the release of Adipsin. Apelin and leptin was detected at very low 
levels. Resistin was secreted upon stimulation with forsk-IBMX but at a 17-fold 
lower level than adiponectin. We thus focused our secretion studies on adiponectin. 
Next, we investigated if adiponectin secretion, similar to adipocyte exocytosis, could 
be stimulated by elevations of cytoplasmic cAMP under Ca2+-free conditions. 
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For this purpose, adipocytes were pre-treated with the membrane-permeable Ca2+ 
chelator BAPTA-AM (30 min) and thereafter exposed to forsk-IBMX. 
Measurements of intracellular cAMP levels confirmed that the cAMP-elevating 
properties of forsk-IBMX were unaltered under Ca2+-free conditions. In agreement 
with the capacitance measurements, adiponectin secretion could indeed be stimulated 
in the absence of Ca2+ and the secretory response was equally potent as that measured 
in cells not exposed to BAPTA (Fig. 8).  
To verify the physiological importance of our findings we investigated if adiponectin 
secretion could be stimulated by cAMP elevation in human subcutaneous adipocytes. 
Forsk-IBMX stimulated adiponectin secretion >2-fold compared to untreated cells 
(Fig 8).  
 
Fig. 8 Elevations of intracellular cAMP stimulate adiponectin secretion. 3T3-L1 
adipocytes (left) were treated with forsk-IBMX under normal or Ca2+-free conditions. 
Adiponectin secretion was also stimulated at lower concentrations of forsk-IBMX in human 
adipocytes. Data are mean values ± SEM of 14 experiments in 
3T3-L1 adipocytes and isolated adipocytes from 4 patients. **P< 0.01; ***P<0.001.  
cAMP stimulates white adipocyte exocytosis and adiponectin secretion 
via activation of Epac 
The effect of cAMP in regulated exocytosis has in other cell types been shown to 
usually be due to activation of PKA, sometimes with contribution of activated Epac 
(Seino & Shibasaki, 2005). To elucidate the pathway involved in regulation of 
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adipocyte exocytosis, we included the specific PKA-inhibitor Rp-8-Br-cAMPS 
together with cAMP in the patch-pipette solution. Somewhat to our surprise, cAMP-
stimulated exocytosis was completely unaffected by PKA inhibition and ΔCm/Δt was 
equal to that in experiments where exocytosis was stimulated by cAMP (Fig. 9). To 
further elucidate the mechanisms of PKA-independent exocytosis, we investigated if 
exocytosis could be triggered by activation of Epac in the absence of cAMP. For this 
purpose we infused cells with the same Ca2+-free pipette solution including the 
specific Epac activator 8-Br-2’-O-Me-cAMP. Epac activation stimulated exocytosis 
as potently as cAMP and ΔCm/Δt was similar to the rate measured upon cAMP-
triggered exocytosis at all time points (Fig. 9). Taken together, our results indicate 
that white adipocyte exocytosis is triggered by cAMP-dependent activation of Epac.  
 
Fig. 9 cAMP stimulates exocytosis via activation of Epac. Left: Example capacitance traces 
of cells infused with cAMP (black), cAMP in combination with the PKA inhibitor Rp-cAMPS 
(red) or with the Epac agonist 8-Br-2’-O-Me-cAMP (blue). Right: The average rates of 
exocytosis (ΔC/Δt) at different time points. Data are mean values ± SEM of 7-9 recordings.   
We next explored the cAMP signalling pathway involved in short-term adiponectin 
secretion. The involvement of PKA was investigated in adipocytes pretreated with 
membrane permeable Rp-8-Br-cAMPS (to inhibit PKA) and subsequently exposed to 
forsk-IBMX (in the continued presence of the PKA inhibitor). Forsk-IBMX remained 
capable of stimulating adiponectin secretion in the presence of the PKA inhibitor, of 
a magnitude similar to that measured in cells exposed to forsk-IBMX alone. 
We further investigated if the membrane-permeable version of the Epac agonist  
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8-Br-2’-O-Me-cAMP-AM stimulated adiponectin secretion in 3T3-L1 and human 
primary subcutaneous adipocytes. In agreement with the Epac-dependent capacitance 
increases recorded in 3T3-L1 adipocytes, adiponectin secretion was stimulated by the 
Epac agonist in both 3T3-L1 and human adipocytes (Fig. 10). Our secretion data thus 
strongly indicate that the capacitance changes recorded in 3T3-L1 adipocytes reflect 
secretion of adiponectin-containing vesicles. Adiponectin release measurements 
further show a similar regulation of adiponectin exocytosis in cultured and primary 
subcutaneous human adipocytes. 
 
Fig. 10 Adiponectin secretion is stimulated via Epac activation. The membrane-permeable 
Epac agonist 8-Br-2’-O-Me-cAMP-AM stimulated adiponectin secretion during 30 min 
incubations in both 3T3-L1 (left) and human (right) adipocytes. Data are mean values ± SEM 
of 11 (3T3-L1 adipocytes) and human adipocytes from three patients. **P< 0.01; ***P<0.001.  
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The role of Ca2+ and ATP in white adipocyte exocytosis 
A combination of Ca2+ and ATP augments cAMP-triggered adiponectin 
exocytosis 
To in detail study the role of Ca2+ in cAMP-stimulated exocytosis, we investigated 
the exocytotic response in cells infused with different concentrations of Ca2+ 
corresponding to 1.5, 0.7 and 0.25 µM free Ca2+. cAMP and ATP were included in 
the pipette solution. As described above, the rate of cAMP-stimulated exocytosis in 
the complete absence of Ca2+ was ~40% lower compared to when 1.5 µM Ca2+ was 
included in the pipette solution. An interesting observation was that the  
cAMP-stimulated capacitance increase reached a steady-state plateau after 
~8 minutes where after no further exocytosis was observed. The plateau value 
indicates that no more vesicles are available for release and that cAMP alone is 
insufficient to sustain the exocytotic response during protracted time-periods. In the 
presence of Ca2+ exocytosis did not plateau but continued for >10 min and 
throughout the duration of the experiments (some lasting as long as 20 min). The lack 
of capacitance plateaus upon infusion of a Ca2+-containing solution indicates the 
presence of a Ca2+-dependent continuous replenishment of vesicles to the pool 
stimulated for release by cAMP.  
Infusion of cells with 0.7 µM Ca2+ also stimulated exocytosis, although at a rate that 
tended to be decreased compared to 1.5 µM Ca2+ (P=0.07). Exocytosis was 
continuous also in the presence of this lower [Ca2+] as shown by the absence of an 
exocytotic plateau in experiments lasting >10 min. Interestingly, a lower [Ca2+] of 
0.25 µM was not sufficient to potentiate exocytosis triggered by cAMP and plateau 
values were again reached, signifying the depletion of readily releasable vesicles. 
The rate of exocytosis using 0.25 µM Ca2+ was equal to ΔCm/Δt in the complete 
absence of Ca2+. 
In order to investigate the role of ATP in cAMP-stimulated exocytosis we infused 
cells with 1.5 µM Ca2+ and cAMP in the absence of ATP. Interestingly, the 
augmenting effect of Ca2+ at early time points (≤6 min) was abolished upon ATP 
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depletion (Fig. 11). However, vesicle replenishment at later time points was 
unaffected. 
 
We next investigated the role of Ca2+ in cAMP-
stimulated adiponectin secretion. 3T3-L1 
adipocytes were incubated with forsk-IBMX 
alone or in combination with the Ca2+ 
ionophore ionomycin (1 µM). Again, forsk-
IBMX stimulated adiponectin secretion >3-fold 
compared to control cells (Fig. 12). The Ca2+ 
elevation induced by ionomycin augmented 
forsk-IBMX-stimulated adiponectin secretion 
2-fold over that produced by forsk-IBMX 
alone. Thus, the Ca2+-potentiating effect 
observed in the secretion measurements is in 
agreement with the augmenting effect of Ca2+ in 
the capacitance recordings.  
Our results indicate that Ca2+ and ATP are 
involved in potentiation of cAMP-stimulated adiponectin vesicle release. The 
augmenting effect involves a direct effect on exocytosis as shown by a Ca2+- and 
ATP-dependent increase of the exocytotic rate at early time-points (already during 
the 2nd minute after start of experiment).  
 
 
Fig. 11 Typical capacitance 
traces of cells dialyzed with 
cAMP alone, cAMP together 
with 1.5 µM Ca2+ or cAMP in 
combination with 1.5 µM Ca2 
and 3 mM ATP, as indicated.  
 
Fig. 12 Ca2+-elevation potentiates 
adiponectin secretion stimulated 
by cAMP. 3T3-L1 adipocytes were 
treated with forsk-IBMX in the 
absence or presence of ionomycin. 
Data are mean values ± SEM of 8 
experiments.**P<0.01; ***P<0.001. 
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Ca2+ further mediates the recruitment of new releasable vesicles from a reserve pool 
in an ATP-independent manner as demonstrated by the continuous exocytosis in cells 
infused with a Ca2+-containing solution lacking ATP.  
Adiponectin vesicles appear as plasma membrane-located 
punctuate structures (unpublished) 
The ultrastructural characteristics as well as the intracellular location of adiponectin-
containing vesicles remain inadequately investigated. However, own unpublished 
results in primary mouse and rat subcutaneous adipocytes immunostained for 
adiponectin and resistin studied with TIRF microscopy shows the abundant existence 
of distinct adiponectin- or resistin-containing vesicles in the sub-plasma membrane 
region (Fig. 13). Since adiponectin and resistin are both released by cAMP elevation 
(described above) it is feasible that the adipokines would be co-released from the 
same vesicle. However, our TIRF data suggests that adiponectin and resistin are 
accommodated in separate vesicle populations. 
 
Fig. 13 Sub-plasma membrane 
adiponectin (green) and resistin (red). 
TIRF image depicting a primary 
subcutaneous mouse adipocyte 
immunostained with primary antibodies 
anti-adiponectin or anti-resistin. 
Secondary antibodies were Alexa-488 
(green) or Dylight 594 (red). Image 
representative of 15 cells in 3 separate 
experiments. 
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Moreover, recent studies from the laboratory of Dr Weiping Han demonstrate 
punctate vesicular structures in the TIRF zone in 3T3-L1 adipocytes transfected with 
adiponectin-venus (Lim et al., 2015) or leptin-venus (Y. Wang et al., 2014). Thus, it 
appears as if white adipocytes contain several populations of plasma membrane-
associated adipokine-containing vesicles.  
Conclusions paper I 
 
 
Fig. 14 Model of regulation of white adipocyte adiponectin exocytosis. See text for details. 
We suggest that white adipocyte adiponectin exocytosis is regulated as described in 
the model in Fig. 14.  A pool of readily releasable adiponectin containing vesicles is 
secreted upon cAMP stimulation via activation of Epac, in a PKA-independent 
manner. The readily releasable pool is refilled by new vesicles residing in a reserve 
pool in a Ca2+-dependent manner. Thus, in the absence of Ca2+ the readily releasable 
pool is depleted and exocytosis can not continue during longer time-periods (seen as 
a plateau in our capacitance measurements). Further, Ca2+ in combination with ATP 
potentiates the cAMP-triggered adiponectin release at early time points (2-6 min). 
It is interesting that adiponectin exocytosis in the white adipocyte, in contrast to the 
Ca2+-stimulated exocytosis in classical (neuro)endocrine cell types (Burgoyne & 
Morgan, 2003), is triggered by cAMP. Pancreatic β-cell exocytosis can be triggered 
by Ca2+ in the absence of cAMP (at a lower rate than in combination with the cyclic 
nucleotide) but cAMP alone is incapable of triggering β-cell exocytosis under 
intracellular Ca2+-free conditions (Renstrom et al., 1997; Eliasson et al., 2003).  
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The regulation of exocytosis in the adipocyte instead shares some similarities with 
how exocytosis is controlled in several exocrine cell types (Seino & Shibasaki, 2005; 
Szaszak et al., 2008). Capacitance measurements in pancreatic acinar cells have 
revealed that cAMP can trigger exocytosis in these cells even under Ca2+-free 
conditions (Sato et al., 2002). Under physiological conditions, the release of amylase 
from pancreatic acinar cells is regulated by an elevation of intracellular cAMP (Seino 
& Shibasaki, 2005).  Furthermore, the downstream regulation of acinar exocytosis 
involves the activation of Epac (Sabbatini et al., 2008). 
A role of Ca2+ in adiponectin secretion has been suggested previously (Bogan & 
Lodish, 1999). Elevations of intracellular Ca2+ were shown to marginally increase 
adiponectin secretion measured between 30-90 minutes, whereas a significant 
stimulation was observed past 90 minutes. This is in reasonable agreement with our 
observation of the potentiating effect of Ca2+ on adiponectin secretion. The earlier 
augmenting effect of Ca2+ observed in our studies is likely due to the concomitant 
elevation of cAMP (and the inclusion of ATP in our electrophysiological recordings) 
making more adiponectin vesicles available for the potentiation by Ca2+. 
Our study is the first to characterize the regulation of adiponectin exocytosis. 
However, controlling mechanisms as well as adiponectin vesicle dynamics and 
maturation steps need to be further investigated. 
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Cooling reduces cAMP-stimulated exocytosis and 
adiponectin secretion at a Ca2+-dependent step in 
3T3-L1 adipocytes (Paper II) 
Most biological processes show rate-temperature dependency. A decrease in 
temperature affects several physicochemical properties and ultimately affects 
biological processes such as enzymatic activity and protein stability (Elias et al., 
2014). Therefore, regulated exocytosis in several (neuro)endocrine cell types show 
sensitivity to alterations in temperature (Bittner & Holz, 1992b; Thomas et al., 1993; 
Renstrom et al., 1996). In this study we explore temperature/energy-dependent steps 
in adiponectin exocytosis. 
Ca2+-dependent potentiation of cAMP-stimulated exocytosis 
is diminished by cooling 
To investigate the temperature sensitivity of adiponectin exocytosis we utilized 
capacitance measurements at 23°C, 27°C, 32°C and 37°C. We normally conduct the 
capacitance measurements at 32°C as it is very difficult to obtain a high resistance 
seal at higher temperatures. The chosen temperature of 32°C is therefore a 
compromise between an increased experimental success rate and the physiological 
temperature of 37 °C. 
As shown in Fig. 15, infusion of 3T3-L1 adipocytes with a pipette solution 
containing 1.5 µM free Ca2+, 0.1 mM cAMP and 3 mM ATP at 32°C stimulated 
exocytosis at a rate similar to that reported in paper I. ΔCm/Δt  (measured during the 
2nd minute after start of infusion) was not significantly altered by a temperature 
increase to 37°C or by decreasing the temperature to 27°C (although the rate of 
exocytosis tended to be reduced at this temperature; P=0.07). However, a decrease of 
temperature to 23°C significantly lowered the exocytotic rate. At 2.5 minutes, 
ΔCm/Δt at 23°C was decreased by ~70% compared to exocytosis at higher 
temperatures. We next infused cells with the same solution lacking Ca2+ (10 mM 
EGTA included; Fig. 15) The Ca2+-depleted solution stimulated exocytosis at 32°C at 
a ~50% lower rate than in the presence of Ca2+, thus again in agreement with results 
in Paper I. Cooling did not affect the exocytotic rate at any investigated temperature. 
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In fact, the rates were at all time points similar to that measured at 23°C with the 
Ca2+-containing pipette solution.  
 
Fig. 15 Cooling is without effect on cAMP-stimulated exocytosis but diminishes the Ca2+-
dependent potentiation. Exocytotic rates at different time points and temperatures for 3T3-L1 
adipocytes infused with cAMP and ATP, in the absence or presence of Ca2+. *P<0.5; 
**P<0.01; ***P<0.001. 
Our results indicate that cooling interferes with the exocytotic process at a step 
upstream of the cAMP-triggered fusion of readily releasable vesicles. This is in 
agreement with a study in pancreatic β-cells by Renström and colleagues. In this 
study it was shown that cooling abolishes cAMP- and ATP-potentiated insulin 
granule replenishment to the same extent as that caused by omitting the nucleotides 
from the pipette solution (Renstrom et al., 1996). 
Ca2+-potentiated adiponectin secretion is diminished by 
cooling 
In order to investigate the temperature sensitivity of adiponectin secretion, 3T3-L1 
adipocytes were incubated for 30 min at 23°C or 32°C and exposed to the membrane 
permeable cAMP analogue 8-Br-cAMP alone or in combination with the Ca2+ 
ionophore ionomycin. 8-Br-cAMP stimulated adiponectin secretion ~1.5-fold over 
control and this effect was equal at both investigated temperatures (Fig. 16). At 32°C 
the combination of 8-Br-cAMP and ionomycin doubled adiponectin secretion 
compared to that stimulated by 8-Br-cAMP alone. However, the ionomycin-induced 
potentiation was completely abolished at 23°C. The effect of temperature was similar 
when adiponectin secretion was instead stimulated by forsk-IBMX. Adiponectin 
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secretion was >3-fold stimulated by forsk-IBMX alone and ionomycin produced a 
>2-fold augmentation of that response at 32°C (Fig. 16). The Ca2+-dependent 
augmentation was again abolished at 23°C. Thus, our secretion measurements are in 
agreement with the electrophysiological recordings and we conclude that Ca2+-
dependent potentiation of adiponectin exocytosis is a temperature-sensitive step. 
 
Fig. 16 Ca2+-potentiated adiponectin secretion is abolished by cooling. Cells were 
stimulated with 8Br-cAMP (left) or Forsk/IBMX (right) in the presence or absence of 
ionomycin at 23°C or 32°C. Data are mean values ± S.E.M. of 11 experiments at each 
temperature in the left and 7 (23°C) and 8 (32°C) in the right histogram.  *P<0.05; **P<0.01; 
***P<0.001 vs. control at corresponding temperature. †P<0.01 vs 8-Br-cAMP or forsk/IBMX 
alone at 32°C; ‡P<0.05 vs. 8-Br-cAMP + ionomycin or forsk/IBMX + ionomycin at 23°C. 
The Q10 values of Ca2+-dependent and Ca2+-independent 
adiponectin exocytosis 
The temperature dependence of a biological process such as vesicle replenishment 
can be calculated by the temperature coefficient Q10. The Q10 coefficient value is the 
factor of which the rate of a process changes when the temperature is increased by 
10°C (Elias et al., 2014). Q10 was estimated to 3.3 and 1.4 for Ca2+-dependent and 
Ca2+-independent adiponectin exocytosis respectively. Processes involving 
enzymatic reactions normally display Q10 values of ≥2 (Elias et al., 2014). Thus, our 
results indicate that the activity of enzymatic proteins involved in the maturation of 
adiponectin vesicles is diminished by cooling, whereas the fusion process itself is 
insensitive to temperature changes. 
 | Results and discussion 41 
 
To investigate the temperature dependence of adiponectin exocytosis in more detail 
we constructed Arrhenius plots to calculate the energy of activation (EA) for cAMP-
triggered and Ca2+-augmented exocytosis. The energy of activation for exocytosis in 
the absence of Ca2+ amounted to 5.7 kJ/mol whereas Ca2+-dependent exocytosis 
required an EA of 53 kJ/mol. The larger EA in the presence of Ca2+ indicates that the 
maturation of vesicles, making them ready for release, is a considerably more energy 
requiring step than the fusion of release ready vesicles. 
The involvement of small G-proteins in adiponectin 
exocytosis (unpublished results) 
Epac is known to activate several 
small G-proteins involved in 
exocytosis (Schmidt et al., 2013). In 
particular the small G-proteins of the 
Ras and Rab subfamilies are known 
regulators of endocrine cell secretion 
(G. G. Holz et al., 2006). Moreover, 
small G-protein activity has been 
shown to be controlled by Ca2+ 
(reviewed in Aspenstrom, 2004) and 
energy in the form of ATP has been 
proposed to be required in order to 
achieve robust stimulation of 
exocytosis by GTPgammaS (non-hydrolysable form of GTP; Okano et al., 1993; 
Proks et al., Eliasson et al., 1997). We thus investigated if GTPgammaS was capable 
of stimulating exocytosis in 3T3-L1 adipocytes. Cells were infused with a non-
stimulatory cAMP-deprived intracellular solution (paper I) lacking Ca2+ (10 mM 
BAPTA included) and supplemented with 3 mM ATP and 100 µM GTPgammaS. As 
shown in Fig. 17, GTPgammaS triggered exocytosis and the rate (ΔCm/Δt) measured 
during the 2nd minute after pipette break-in averaged 16±4 fF/s, comparable to that 
upon stimulation by dialyzing cAMP (ΔCm/Δt=16±6 fF/s). Interestingly, while 
adipocyte exocytosis triggered by cAMP in the absence of intracellular Ca2+ reaches 
 
Fig. 17 GTPgammaS stimulates 
adipocyte exocytosis. Examples of 
change in cell capacitance (ΔCm) upon 
stimulation with GTPgammaS (n=10) 
or cAMP (n=6), as indicated. 
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a plateau within ~10 min (signifying depletion of a readily releasable vesicle pool: 
paper I) GTPgammaS-stimulated exocytosis continued for an extended time-period 
and ΔCm/Δt at t=10 min averaged 13±4 fF/s (n=8). Our results indicate, in analogy to 
what has been shown in other secretory cell types (Okano et al., 1993; Proks et al., 
1996), an involvement of a GTP-dependent step in white adipocyte exocytosis. GTP-
dependent mechanisms appear to regulate both the release process itself as well as 
the recruitment of new releasable vesicles. Further, GTPgammaS still triggered 
exocytosis when ATP was excluded from the pipette filling solution but at a lower 
rate (ΔCm/Δt =8±2 fF/s; n=6) confirming, in analogy to findings in other secreting 
cell types (Okano et al., 1993; Proks et al., 1996; Eliasson et al., 1997), the 
energy/ATP requirement for a robust GTPgammaS stimulation. 
Conclusions paper II 
 
 
Fig. 18 Model of the effect of cooling on white adipocyte adiponectin exocytosis. See text 
for details. 
The temperature-dependence of adiponectin exocytosis shown in our study clarifies 
regulatory mechanisms involved in vesicle recruitment/maturation needed for 
augmentation and long-term maintenance of adiponectin release. In agreement with 
the model in Fig. 18, cAMP-stimulated exocytosis of release ready adiponectin 
vesicles is unaffected by cooling while the Ca2+/ATP-dependent augmentation of 
secretion is an energy-dependent process affected by a temperature drop. Exocytosis 
in several secreting cell types requires ATP hydrolysis, for vesicle replenishment and 
for several other steps prior to the fusion process (Burgoyne & Morgan, 2003). We 
thus suggest that the temperature-dependence of adiponectin exocytosis mainly is 
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due to the need of ATP hydrolysis to generate energy for recruitment/maturation of 
new releasable vesicles. The effect of ATP may involve phosphorylation of 
exocytotic proteins.  
The EA of 53 kJ/mol for Ca2+-dependent adiponectin exocytosis is lower than what 
has been reported for sustained insulin secretion (145 kJ/mol; Renstrom et al., 1996). 
However, vesicle replenishment in the β-cell is a highly energy-dependent process 
due to its rather small pool of readily releasable insulin granules. 
Our infusion experiments demonstrate that GTPgammaS stimulates adipocyte 
exocytosis and that ATP is required to achieve a potent GTPgammaS stimulation. 
We propose that Ca2+- and ATP-dependent activation of small G-proteins is part of 
the signalling pathway downstream of Epac involved in stimulation of adiponectin 
exocytosis. Interestingly, reduced levels of small G-proteins have been correlated to 
diabetes in rodent models (Fukuda, 2008). 
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White adipocyte adiponectin exocytosis is 
stimulated via β3 adrenergic signalling and 
activation of Epac1 – catecholamine resistance in 
obesity and type 2 diabetes (Paper III) 
The central roles of cAMP and Ca2+ in adiponectin exocytosis propose adrenergic 
signalling as a likely physiological regulator of acute adiponectin secretion. Although 
insulin has been shown to induce adiponectin release (Bogan & Lodish, 1999; 
Motoshima et al., 2002; Pereira & Draznin, 2005; Cong et al., 2007; Blümer et al., 
2008; Li et al., 2013; Lim et al., 2015) the physiological regulator of adiponectin 
exocytosis has not yet been established. In this study we investigate the hypothesis 
that adrenergic stimulation is the physiological trigger of adiponectin 
exocytosis/secretion. We further explore how this regulation might be disturbed in 
obesity and type 2 diabetes. 
White adipocyte exocytosis is stimulated via adrenergic 
pathways and activation of Epac1 
We analyzed the relative gene expression of the five ARs and the two Epac isoforms 
(Epac1 and Epac2) in undifferentiated and differentiated 3T3-L1 adipocytes. The β3-
AR was highly expressed in mature adipocytes and lower expression levels could be 
detected for α1d-, β2- and the β1-ARs. The two isoforms of Epac have tissue-
dependent expression (reviewed in Schmidt et al., 2013). In agreement with what has 
previously been described (Petersen et al., 2008) we found the Epac1 isoform to be 
expressed in 3T3-L1 adipocytes whereas Epac2 was undetectable. In accordance with 
the shown role for Epac1 in adipocyte differentiation (Petersen et al., 2008; Jia et al., 
2012), the cAMP-GEF was highly expressed in undifferentiated cells. Epac1 was still 
readily expressed in mature adipocytes, although at a reduced level (~60% lower than 
in undifferentiated cells).  
To investigate the involvement of ARs in 3T3-L1 adipocyte exocytosis, cells were 
infused with a non-stimulatory pipette solution lacking cAMP and Ca2+ (10 mM 
EGTA and 3 mM ATP included). Adrenaline (5 µM) was added in the extracellular 
solution perfusing the cell dish ~4 min after establishment of the standard whole-cell 
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configuration. At the time of catecholamine addition no capacitance increase 
(exocytosis) could be observed, thus consistent with previous results using this 
cAMP-depleted solution (Paper I). As shown in Fig.19, adrenaline stimulated 
exocytosis potently and the maximum rate of exocytosis (ΔC/Δtmax) was ~19 fF/s. 
Interestingly, this rate was not significantly different from when exocytosis was 
stimulated with a pipette solution containing cAMP (~15 fF/s). 
Due to the high abundance of β3-ARs we investigated the contribution of this 
receptor to the exocytotic response evoked by adrenaline. Cells were again infused 
with the non-stimulatory pipette solution and the β3 agonist CL 316,243 (1 µM; CL) 
was added ~4 min after start of the recording. Exocytosis was stimulated by the β3-
agonist and the rate of exocytosis was similar to the rate induced by adrenaline at all 
measured time points (Fig. 19). 
To investigate the role of Epac in adrenergic stimulation of adipocyte exocytosis, we 
pre-treated 3T3-L1 adipocytes with the Epac inhibitor ESI-09 (10 µM) for 30 min. 
Cells were infused with the non-stimulatory pipette solution and adrenaline was 
again added extracellularly. Epac inhibition completely abolished adrenaline 
stimulated exocytosis at all measured time points (Fig. 19). 
 
Fig. 19 Adrenaline or CL stimulates exocytosis via β3-AR mediated activation of Epac. 
Left: Example capacitance traces of cells dialyzed with a non-stimulatory pipette solution 
lacking cAMP with extracellular addition of CL or adrenaline as indicated by arrows. Green 
trace depicts cells pre-treated for 30 min with the membrane permeable Epac agonist ESI-09. 
Right: Exocytotic rates at different time points after ΔC/Δtmax. i is the initial rate of exocytosis 
prior to addition of ADR or CL. Data are mean values ± SEM of 6 (ADR), 7 (ADR+ESI-09) 
and 8 (CL) recordings.  
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Role of Ca2+ in adrenergically stimulated adipocyte 
exocytosis  
Adrenaline is known to elevate intracellular Ca2+ levels by activation of the α1d-AR 
and gene expression data indicated the presence of this receptor in 3T3-L1 
adipocytes, although at low levels. To investigate how adrenaline affects [Ca2+]i 
levels in 3T3-L1  adipocytes, the catecholamine was added extracellularly and [Ca2+]i 
levels were measured by ratiometric Ca2+ imaging. Adrenaline stimulated elevations 
of [Ca2+]i in ~60% of the 3T3-L1 adipocytes while [Ca2+]i was unaffected by 
catecholamine addition in the remaining 40% of cells. Elevations in [Ca2+]i were 
characterised by high amplitude oscillations, one or several peaks or a slow increase 
over several minutes. The different response patterns may depend on an uneven inter-
cellular distribution of the AR subtypes and similar observations have previously 
been reported in human adipocytes exposed to noradrenaline (Seydoux et al., 1996).  
To investigate the contribution of [Ca2+]i to catecholamine-stimulated adipocyte 
exocytosis, we added adrenaline to cells infused with a solution containing a lower 
[EGTA] of 50 µM to allow for fluctuations of [Ca2+]i. The exocytotic response was 
not augmented under those conditions and the maximal rate of exocytosis was if 
anything smaller when [Ca2+]i was allowed to vary compared to when Ca2+ was 
chelated by EGTA (ΔC/Δtmax= 11±2.5 fF/s at 50 µM EGTA vs. 19±4.1 fF/s; P=0.1). 
To investigate if CL-triggered exocytosis, in accordance with our model of 
adiponectin exocytosis presented in paper I, could be potentiated by higher 
intracellular Ca2+ levels 3T3-L1 adipocytes were infused with a pipette solution 
lacking cAMP and containing ~1.5 µM free Ca2+. In agreement with previous results 
(paper I), Ca2+ alone did not trigger exocytosis. CL, added ~3.5 min after start of the 
recording, stimulated exocytosis and the maximal rate achieved was ~60% higher 
than under Ca2+-free conditions although this increased rate did not quite reach 
statistical significance (ΔC/Δtmax= 31±8 fF/s vs. 17±3.2 fF/s; P=0.08). 
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Adrenergic stimulation triggers adiponectin secretion 
mainly via β3-ARs 
Next we investigated the effect of adrenergic stimulation on short-term adiponectin 
secretion. 3T3-L1 adipocytes were incubated for 30 minutes in the presence of 5 µM 
adrenaline or 1 µM CL. Adrenaline stimulated adiponectin secretion ~1.8-fold 
compared to control conditions. The stimulation was equally potent in cells 
stimulated with CL, suggesting that adrenergic stimulation of adiponectin exocytosis 
occurs chiefly via activation of β3-ARs with little involvement of signalling via other 
ARs. To investigate the role of Ca2+ in adrenergically stimulated adiponectin 
secretion, 3T3-L1 adipocytes were pre-treated with the membrane permeable Ca2+-
chelator BAPTA-AM and thereafter stimulated with adrenaline or CL. Adrenaline 
and CL stimulated adiponectin secretion of a similar magnitude under Ca2+-free 
conditions and in cells not exposed to BAPTA.  
Measurements of intracellular cAMP content in cells stimulated with adrenaline or 
β3 agonist showed a >7.5-fold and 3-fold elevation respectively compared to 
unstimulated cells. Under Ca2+-free conditions (BAPTA pre-treatment) adrenaline-
induced cAMP production was decreased to levels similar to that produced by CL 
whereas CL-mediated cAMP levels were unaffected by Ca2+ chelation. Our cAMP 
measurements indicate a role for Ca2+ in the adrenaline-induced elevation of cAMP, 
likely by activation of Ca2+-dependent AC activity (Halls & Cooper, 2011). 
However, the 3-fold increase of cAMP levels generated by CL stimulated 
adiponectin secretion as potently as adrenaline that elevates cAMP >7-fold. Thus, our 
results indicate that the Ca2+ elevation induced by adrenaline has a minor role in 
adiponectin exocytosis. 
In order to verify the physiological importance of our findings using 3T3-L1 
adipocytes, we investigated the effect of adrenaline and CL on adiponectin secretion 
under normal or Ca2+-free conditions in primary subcutaneous mouse adipocytes. In 
30 minute incubations adrenaline and CL stimulated adiponectin secretion ~2-fold 
and the stimulation was unaffected by BAPTA pre-treatment. Based on our 
electrophysiological findings of the Epac-dependence of adrenergically stimulated 
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exocytosis, we investigated adiponectin secretion in primary adipocytes pre-treated 
with ESI-09. Epac inhibition abolished adiponectin secretion stimulated by both 
adrenaline and CL. Our data show that adrenaline and CL stimulates adiponectin 
secretion by activation of Epac in both 3T3-L1 and primary mouse adipocytes. The 
results further demonstrate that the stimulation is independent of Ca2+.  
Adiponectin secretion is disturbed in adipocytes from 
obese and diabetic mice 
To investigate how the physiological regulation of adiponectin secretion might be 
disturbed in obesity and type 2 diabetes, subcutaneous adipocytes were isolated from 
mice fed a chow or high fat diet (HFD) for 8 weeks. The HFD animals were obese 
and displayed a diabetic phenotype as shown by elevated plasma glucose (307±14 
mg/dl in HFD vs. 234±11 mg/dl in chow; P<0.001) and insulin (4.0±0.7 ng/ml in 
HFD vs. 1.5±0.1 ng/ml in chow; P<0.01). Adipocytes from chow or HFD animals 
were stimulated with forsk-IBMX, adrenaline or CL during 30 min incubations. In 
agreement with a previous study (Lin et al., 2013), basal adiponectin secretion was 
>2-fold elevated in HFD adipocytes compared to adipocytes from chow-fed animals. 
Forsk-IBMX stimulated adiponectin secretion 2.5-fold in adipocytes from chow-fed 
animals and adrenaline and CL stimulated adiponectin secretion ~2-fold, thus to a 
similar extent as in 3T3-L1 adipocytes. Adiponectin secretion could be induced by 
forsk-IBMX also in HFD adipocytes, although of a magnitude significantly lower 
than that observed in adipocytes isolated from chow-fed mice (~1.5-fold; P<0.05 vs. 
chow adipocytes). Interestingly, adrenaline- and CL-stimulated adiponectin secretion 
was abolished in HFD adipocytes (Fig. 20). 
To investigate if the diminished adiponectin levels were due to decreased cellular 
adiponectin content we measured total adiponectin in adipocytes from chow- and 
HFD-fed animals. The total adiponectin content was not significantly decreased in 
HFD adipocytes (~30% reduced, P=0.1) thus indicating other underlying causes for 
the secretory disturbance. 
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Fig. 20 Adrenergically stimulated adiponectin secretion is blunted in adipocytes from 
HFD mice. Primary subcutaneous adipocytes from animals fed chow or HFD were stimulated 
with forsk-IBMX, adrenaline or CL during 30 min incubations. Data are mean values ± SEM 
of 9 (chow) and 13 (HFD) animals. *P<0.05; **P<0.01 
Gene expression analysis showed that adipocytes from chow-fed animals expressed 
high levels of β3-ARs and that α1d-, β2- and β1-ARs were expressed at lower levels. 
Moreover, the Epac1 isoform was present whereas Epac2 was undetectable. Thus, 
expression data from primary adipocytes were very similar to results in 3T3-L1 
adipocytes. Interestingly, the β3-ARs were 5-fold down-regulated in adipocytes from 
HFD-fed mice and mRNA levels for the β1-receptor were reduced 3.5-fold. 
Expression of Epac1 was reduced by 40% in HFD adipocytes compared to chow 
adipocytes. 
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Conclusions paper III 
 
Fig. 21 Model of adiponectin exocytosis in health (left part) and in metabolic disease 
(right part). See text for details. 
Our results show that adiponectin exocytosis/short-term secretion is stimulated by the 
catecholamine adrenaline as well as by the β3 agonist CL. We further demonstrate 
that this stimulation is dependent on Epac. Our findings are in accordance with 
results in Paper I showing that cAMP stimulates adiponectin exocytosis via 
activation of Epac. Moreover, gene expression analysis identified Epac1 as the 
isoform present in both cultured and primary adipocytes and thus the Epac isoform 
involved in regulation of adiponectin exocytosis. In agreement with the left part of 
the model in Fig. 21, we propose that catecholamines stimulate adiponectin 
exocytosis mainly by activation of β3-ARs resulting in an elevation of cAMP and 
activation of Epac1. 
Signalling via α1-ARs appears to be of minor importance in adiponectin exocytosis, 
as shown by the lack of effect of Ca2+ chelation on adrenaline stimulated adiponectin 
secretion. The effects of adrenaline on adipocyte [Ca2+]i are small and 40% of the 
cells did not respond at all with a change in [Ca2+]i upon adrenaline exposure. 
Nonetheless, measurements of cAMP levels in the presence and absence of Ca2+ 
indicate that Ca2+-dependent ACs are activated upon adrenaline stimulation. This 
finding may seem contradictory to the inability of adrenaline to stimulate adiponectin 
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exocytosis beyond that triggered by CL. However, we propose that the 3-fold 
elevation of cAMP produced by CL is sufficient to maximally stimulate adiponectin 
exocytosis. Due to cAMP compartmentalization (Stefan et al., 2007), the additional 
cAMP produced by activation of Ca2+-dependent ACs may be involved in other 
cellular processes such as regulation of lipolysis (Ohisalo, 1980; Izawa & 
Komabayashi, 1994). In adiponectin secretion the cAMP signalling may be further 
localized to specific sub-cellular regions due to restricted distribution of Epac1 
(Schmidt et al., 2013). We conclude that the effect of adrenergically elevated Ca2+ on 
adiponectin exocytosis is of little importance. However, the role of Ca2+ to potentiate 
cAMP-stimulated adiponectin exocytosis is clear (Paper I and II). We suggest that 
other pathways leading to an elevation of [Ca2+]i are more important for this 
augmenting effect. 
In contrast to the stimulatory effect of adrenergic signaling demonstrated here, a few 
studies have shown that long-term (several hours or days) adrenergic receptor 
activation leads to reduced expression and/or secretion of adiponectin (Fasshauer et 
al., 2001; Delporte et al., 2002; Cong et al., 2007; Fu et al., 2007). In one of these 
studies, the strongest inhibitory effect on adiponectin secretion was observed when 
β3-ARs were targeted specifically (Delporte et al., 2002). It is feasible that this long-
term detrimental effect of catecholamines on adiponectin secretion is attributable to 
depletion of adiponectin-containing vesicles, similar to how pancreatic β-cells 
exposed to extended stimulation of insulin release are exhausted (Robertson et al., 
2003). Further, sustained exocytosis of adiponectin is a Ca2+- and energy-dependent 
step requiring the presence of ATP (Paper II). It has been shown that β-adrenergic 
stimulation of adipocytes with consequent activation of ACs leads to ATP depletion 
(the substrate for cAMP production; Chung et al., 1985). Thus, long-term adrenergic 
stimulation of adiponectin secretion in the absence of necessary substrates for vesicle 
replenishment can be envisaged to keep the adipocyte in a state where replenishment 
of releasable vesicles is blocked.  
Our investigations further demonstrate that adrenergically stimulated adiponectin 
exocytosis is disrupted in adipocytes isolated from obese/diabetic mice. As shown in 
the right part of the model in Fig. 21, we propose that the blunted catecholamine 
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stimulation of adiponectin exocytosis is mainly due to a marked lower expression of 
β3-ARs. The ability of forsk-IBMX to still stimulate adiponectin secretion in 
adipocytes from obese mice, although at a lower level, indicates that post-receptor 
signalling is partly intact. However, as shown in the model Fig. 21, we suggest that 
the demonstrated reduction of Epac1 contributes to the disturbed secretion. It is 
interesting that the magnitude of forsk-IBMX-stimulated adiponectin secretion is 
reduced by a similar magnitude as Epac1 expression (~40%), indicating that the 
disturbed post-receptor effect on adiponectin exocytosis is chiefly due to the lower 
abundance of the cAMP-GEF. The combined marked reduction of β3-ARs and a 
down-regulation of Epac1 results in blunted catecholamine-stimulated adiponectin 
exocytosis. It is interesting that the basal secretion of adiponectin is 2-fold higher in 
adipocytes isolated from obese mice compared to lean littermates. It is possible that 
basal (unstimulated) secretion is elevated to compensate for the reduced stimulated 
adiponectin release. 
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Pathophysiological implications and future 
directions of our studies  
The discovery of white adipose tissue as an endocrine organ was a big leap forward 
in understanding the importance of this tissue in metabolic health and longevity. 
There is not a single organ or cell in the body that is not directly or indirectly affected 
by the adipose tissue. Our studies elucidate both the mediators and mechanisms 
regulating adiponectin exocytosis under normal physiological conditions as well as 
how those mechanisms are disturbed in obesity and metabolic disease in a condition 
we characterise as catecholamine resistance. The group of Prof Arner first described 
the occurrence of catecholamine resistance in human obesity in the early 90s when 
they showed that lipolytic noradrenaline insensitivity arose as a result of a low 
density of β2-ARs (Lonnqvist et al., 1992; Reynisdottir et al., 1994).  
The elevated basal secretion of adiponectin observed in adipocytes isolated from 
obese mice is somewhat difficult to reconcile with the reported decreased plasma 
adiponectin levels in obesity/type 2 diabetes. Again, this elevated adiponectin release 
is perhaps a transient condition and reduced basal secretion may occur at later stages 
of metabolic disease development. Serum adiponectin levels measured after 4 weeks 
have in a previous study been shown to be higher in HFD compared to chow fed 
mice but this elevation was reversed after 35 weeks of HFD (Lin et al., 2013). In line 
with this observation, own preliminary results indicate that basal adiponectin release 
is distinctly reduced in adipocytes isolated from animals fed HFD for 20 weeks 
(Musovic, Komai, Olofsson, unpublished). It should also be noted that the ratio 
between HMW and total adiponectin rather than the total adiponectin levels has been 
suggested to be affected in obesity/diabetes (Pajvani et al., 2004; Murdolo et al., 
2009). 
Insulin has in several studies been suggested to be the physiological regulator of 
adiponectin secretion (Scherer et al., 1995; Bogan & Lodish, 1999; Motoshima et al., 
2002; Pereira & Draznin, 2005; Blümer et al., 2008). Furthermore, the reported 
inhibitory effect of elevated cAMP on adiponectin secretion (Delporte et al., 2002; 
Cong et al., 2007; Fu et al., 2007)  has been reported to be reversed by insulin  
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(Cong et al., 2007). However, a recent study shows that insulin-stimulated 
adiponectin secretion in 3T3-L1 adipocytes is evident first at time-points around 30 
min (Lim et al., 2015). Those studies are in agreement with own unpublished time-
course secretion studies in cultured and primary adipocytes showing that forsk-
IBMX stimulates adiponectin secretion after ~5 min while the stimulatory effect of 
insulin is evident after 20-30 minutes (Musovic, Brännmark, Komai, Olofsson, 
unpublished). Thus, based on published results and our own preliminary data we 
propose that insulin is not a physiological regulator of white adipocyte adiponectin 
exocytosis. We instead suggest that insulin affects adiponectin release in the longer 
term, perhaps by an elevation of “constitutive-like” adiponectin release involving an 
endosomal pathway (Clarke et al., 2006; Xie et al., 2008), functionally different from 
adrenergically triggered adiponectin vesicle release. Further studies are merited in 
this field to clarify the mechanisms of insulin action on adiponectin release. 
The observations that an elevation of adiponectin levels decreases the risk of 
developing metabolic disease (Spranger et al., 2003) indicate that adiponectin may be 
an interesting pharmacological target. Recombinant adiponectin is difficult and 
expensive to produce due to complex post-translational modifications. An agonist of 
adiponectin receptors (AdipoRon) has recently been developed (Okada-Iwabu et al., 
2013) but further investigations are required regarding the specificity and effects of 
this compound. In addition, efforts should be aimed at elevating endogenous 
adiponectin secretion. In order to correct secretory defects the mechanisms regulating 
adiponectin exocytosis as well as how the regulation is disturbed in obesity/type 2 
diabetes need to be established. The results presented in this thesis moves us one step 
closer to resolving obesity-related defects of adiponectin secretion. 
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Concluding remarks  
In this thesis we have, for the first time, characterized the intracellular mediators and 
mechanisms involved in stimulation of white adipocyte adiponectin exocytosis. 
We have further determined adrenergic signalling as a physiological trigger of 
adiponectin exocytosis/secretion. Finally, we have shown that catecholamine 
stimulation of adiponectin exocytosis is disturbed in obesity and type 2 diabetes due 
to a malfunctioning adrenergic signalling pathway. The following conclusions were 
reached: 
1) White adipocyte exocytosis is stimulated by cAMP and activation of Epac, 
in a Ca2+- and PKA-independent manner. The cAMP-triggered exocytosis 
can however be greatly augmented by a combination of Ca2+ and ATP via a 
direct effect on the release process as well as via recruitment of vesicles 
residing in a reserve pool. The exocytotic responses (increases in membrane 
capacitance) can be largely correlated to release of adiponectin-containing 
vesicles. 
2) The cAMP-triggered adiponectin exocytosis is unaffected by cooling while 
the Ca2+/ATP-dependent augmentation of release is largely reduced by a 
temperature decrease. We propose that cooling affects adipocyte 
exocytosis/adiponectin secretion at a Ca2+-dependent step, likely involving 
ATP-dependent processes, essential for amplification of cAMP-stimulated 
adiponectin secretion. 
3) Adrenergic signalling is the physiological trigger for adiponectin exocytosis. 
Catecholamines stimulate the release of adiponectin-containing vesicles 
mainly via binding to β3-ARs and activation of Epac1. Adrenergically 
stimulated adiponectin secretion is disturbed in obesity/type 2 diabetes due 
to a marked lower abundance of β3-ARs and reduced expression of Epac1 
in a state we define as catecholamine resistance. 
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Populärvetenskaplig sammanfattning 
Dagens fetmaepidemi är ett faktum. Idag dör fler människor av överviktsrelaterade 
sjukdomar än undervikt. Övervikt kan leda till en rad olika sjukdomar och tillstånd, 
bland annat hjärt- och kärlsjukdomar, stroke, inflammation och alltmer vanligt  
typ-2 diabetes. Övervikt karaktäriseras av en ökad storlek av kroppens vita fettväv. I 
den vita fettväven finns flera olika celltyper, men den största delen består av vita 
adipocyter (fettceller) som är kroppens enda celltyp som är specialiserad för att lagra 
fett och överskottskalorier vi får i oss från födan. Historiskt sett har den vita 
fettväven endast betraktats som ett passivt förvaringsorgan för fett, men på senare år 
har forskning visat att fettväven är ett ytterst komplext endokrint organ. Från 
fettväven frisätts ett flertal olika biologiskt aktiva protein-molekyler och hormoner 
som kallas för adipokiner. Adipokiner frisätts direkt in i blodet och fettväven kan på 
detta sätt direkt eller indirekt kommunicera med och påverka hela kroppen. 
Adiponektin är ett hormon som frisätts från den vita adipocyten och har sedan dess 
upptäckt för 20 år sedan fått väldigt stor uppmärksamhet på grund av dess positiva 
effekter. Adiponektin kallas för ett anti-diabetiskt hormon och har visats kunna öka 
bland annat insulin-känslighet, glukosupptag och fettförbränning. Höga 
adiponektinnivåer kan därför skydda mot utveckling av typ-2 diabetes. Adiponektin 
har också anti-inflammatoriska egenskaper och kan också ha en skyddande roll i 
hjärt- och kärlsjukdomar. Till skillnad från flertalet andra kända adipokiner så 
minskar paradoxalt nog frisättningen av adiponektin med ökad fettmassa och nivåer 
är därför lägre i patienter med övervikt och typ-2 diabetes. Trots all forskning om de 
hälsofrämjande effekterna av adiponektin och de negativa konsekvenserna av 
minskade adiponektinnivåer, är mekanismerna som reglerar fettcellernas frisättning 
av detta hormon fortfarande i stort okända. 
Hormonfrisättande celler har oftast en färdig depå av hormoner lagrade i små 
”blåsor” som kallas för vesiklar och som kan frisättas från cellen som svar på en 
fysiologisk stimulering. När de frisättningsbara vesiklarna är slut kan nya 
hormoninnehållande vesiklar snabbt genomgå ett eller flera mognadssteg för att 
kunna frisättas och därmed upprätthålla hormonfrisättningen. Frisättningen av mogna 
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vesiklar stimuleras vanligen av kalcium-joner (Ca2+), och vesikelmognaden 
involverar bland annat de intracellulära mediatorerna adenosintrifosfat (ATP) och 
cykliskt-AMP (cAMP). Vid frisättningsprocessen, som kallas för exocytos, smälter 
den hormoninnehållande vesikeln ihop med cellens plasmamembran och 
vesikelinnehållet släpps ut utanför cellen. Exocytos leder till att cellmembranets area 
ökar och detta kan experimentellt mätas på enskilda celler med patch-clamp tekniken 
som en ökning av en elektrisk egenskap som heter kapacitans. I detta 
avhandlingsarbete har jag, med en kombination av kapacitansmätningar och 
biokemiska mätningar av frisatt adiponektin, karaktäriserat mekanismer och 
signalvägar som styr exocytos av adiponektin i vita adipocyter. 
Vår forskning visar, för första gången, att exocytos i den vita adipocyten stimuleras 
av cAMP och att exocytosen huvudsakligen motsvarar frisättning av adiponektin. 
Denna cAMP-stimulerade exocytos skiljer alltså adipocyten från flertalet 
hormonfrisättande celler där exocytosen är Ca2+-stimulerad. Dock kan den cAMP-
triggade exocytosen förstärkas av en kombinerad närvaro av ATP och Ca2+ som har 
en essentiell roll i mognadsprocessen av nya frisättningsbara vesiklar. Den Ca2+ och 
ATP-beroende mognaden/påfyllnaden av frisättningsbara vesiklar kräver energi i 
form av ATP. Våra studier visar vidare att den cAMP-stimulerade exocytosen 
motsvarar frisättningen av vesiklar innehållandes adiponektin. cAMP kan signalera 
antingen via aktivering av enzymet protein kinas A (PKA) eller via aktivering av det 
cAMP-specifika proteinet Epac. Ännu ett intressant och viktigt fynd i vårt arbete är 
att exocytos av adiponektin verkar stimuleras enbart via Epac, helt oberoende av 
PKA. Detta skulle kunna vara ett sätt för adipocyten att skilja mellan cAMP-
stimuleard adiponektinfrisättning och fettförbränning (som stimuleras via PKA). 
Våra studier visar också att adiponektinfrisättning fysiologiskt stimuleras via 
aktivering av membranbundna adrenerga receptorer. Det finns flera olika adrenerga 
receptorer (uppdelade i alfa och beta) som bland annat binder till och stimuleras av 
katekolaminet adrenalin, ett hormon som utsöndras från binjurebarken. När beta-
adrenerga receptorer aktiveras leder det till en ökning av cAMP inuti cellerna. Våra 
resultat demonstrerar att adrenalin-medierad aktivering av adrenerga beta-3 
receptorer är viktigast för adiponektinexocytosen och att den påföljande ökningen av 
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cAMP stimulerar exocytosen via Epac1. Vi visar även att signalleringen via 
adrenerga beta-3 receptorer är störd i adipocyter isolerade från överviktiga och 
diabetiska möss och att detta beror på en nedreglering av beta-3 receptorn och Epac1 
i de feta djuren.  
För effektiva behandlingar av fetma och alla dess följdsjukdomar krävs en grundlig 
förståelse för hur fettcellen fungerar. Betydelsen av en hälsosam fettväv och intakt 
frisättningen av adiponektin för en god hälsa är uppenbar. Våra studier utgör därmed 
en viktig pusselbit i vår strävan att förstå de mekanismer som reglerar frisättningen 
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